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Interest in veratrum has varied considerably since the first 
description of this agent by Hippocrates. It is best known for its 
actions on the circulatory system, namely, a fall in blood pressure 
and bradycardia. Recent success in the isolation of active principles 
from veratrum has stimulated clinical application of these agents in 
the treatment of hypertensive states. The exact site or sites of 
action of these compounds have not been adequately elucidated; there-
fore, an investigation of the cardiovascular effects of the veratrum 
derivatives was undertaken. 
The sources of the veratrum alkaloids are the roots and rhizomes 
of several species of liliaceous plants. These include sabadilla or 
cevadilla (Schoenocaulon officinale) found mainly in Mexico and the 
West Indies, Veratrum album, found mainly in Europe, Veratrum viride, 
Veratrum Fimbriatum and Veratrum eschocholtzii which are native to the 
United States and Canada. The purified alkaloids which have been iso-
lated from these various species are listed in table 1. 
Veratrum alkaloids are all tertiary amines with the exception of 
jervine which is a secondary amine, and they are closely related to 
the solanum alkaloids as well as to the cardiac glycosides. Each con-
tains one ethanolic linkage and has all its oxygen atoms in the form 
of hydroxyl groups. The nucleus of these alkaloids is a cyclopenteno-
phenantbrene structure. To date, 28 purified alkaloids have been iso-
lated and characterized. The more important chemical properties of 
these derivatives are presented in table 2. 
Powdered veratrum and various extracts have found wide application 
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Table 1 
Alkaloids of the Various Species of Veratrum 
Veratrum album 
Jervine 
Rubijervine 
Isorubijervine 
Pseudojervine 
Protoveratridine 
Protoveratrine 
Germine 
Germerine 
Veratramine 
Protoverine 
Veralbidine 
Neogermitrine 
Sabadilla 
Cevadine 
Cevadilline 
Cevine 
Veracevine 
Veratridine 
Veratrum viride 
Jervine 
Rubijervine 
Pseudojervine 
Protoveratridine 
Germine 
Veratrosine 
Veratramine 
Veratridine 
Cevadine 
Germerine 
Germitrine 
Germidine 
Isorubijervine 
Protoveratrine 
Neoprotoveratrine 
Veratrum fimbriatum 
Germani trine 
Germinitrine 
Neogermitrine 
Jervine 
Pseudojervine 
Veratroylzygadenine 
Veratrum esehoeholtzii 
Isorubijervosine 
Pseudojervine 
Veratrosine 
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Table 2 
Chemical Characteristics of Veratrum Derivatives 
&Jpirical Melting Prepared Alkamine Type Point [o<.] Reference Fonnula oc D by hydrolysis of: 
/ 
Cevine Tertiary C27li4308N 195-200 -17 .5(ETOH) Cevadine and Wright and 
Amine -15.4(MeOH) Veratridine Luff 1878 
-30.8(Acetone) 
Germine Tertiary c27£t308N 220 +5(ETOH) Gennine, Germidine Craig and 
Amine +21(10% Acetic Germitrine and Jacobs 194 3 
acid) Protoveratridine 
Isogermine c271\3°8N 26o -46.5(ETOH) Craig and 
Jacobs 194 3 
Isojervine C27H39°Yi -32.5(ETOH) Jacobs and Craig 1943 
Isoprotoverine C27lt3°9N 240-264 -42(Pyridine) Jacobs and Craig 1943 
--- ------ - - - -- --- - --- - -- -- --- --- - - --- - --------- ·---- ------
I..U 
Table 2 (cont1d)-2 
Empirical Melting Prepared Alkamine Type Formula Point Co(:J by hydrolysis of: Reference oc D 
Isorubijervine Tertiary c27H43o~ 218 t9.4(ETOH) Pelletier and 
Amine (Needles) Jacobs 1953 
241-244 
(Prisms) 
Isorubijervosine Second.aly C33H5307N 279-280 -20 (Pyridine) Klohs et 
Amine al 1953 
Jervine Seconda.ry C27H39°~ 241-246 -J..47(ETOH) Pseudojervine Jacobs and Amine Craig 1943 
Protoverine Tertiary C27lt3°9N 195-200 -12 (Pyridine) Protoveratrine ·Jacobs and 
Amine Craig 1943 
Rubijervine Tertiary c27H43°~ 240-242 +19(ETOH) Jacobs and Amine Craig 1943 
Veracevine Alkanol- C27%3°8N 181-183 -24(ETOH) Cevadine and Pelletier and 
amine Veratridine Jacobs 1953 
Veratramine Second.aly C27H39°~ 209- -68(Me0H) Veratrosine Jacobs and Amine 210.5 Craig 1945 
--
- -
L_ __ 
.j::-" 
Table 2 (cont1d)-3 
Empirical Melting 
Alkaloid Type Formula Point Cd.. ::Jl Acid or Sugar Reference 
oc D 
Cevadilline Monoester C.34H.5308N Tiglic acid Wright and 
Luff 1878 
Cevadine Diester C32H~90 9 N 20.5 +12.5(ETOH) Tiglic acid Wright and 
+6 • .5 (Pyridine) and Luff 1878 
+1.25(Acetone) Angelic acid 
Germani trine Triester C39H.59011N 228-229 -61) cl.O in py) Acetic acid, tiglic Klohs et 
o.o(cl.l.5 in CHCl3) acid, 1 o<methylbutyric al 19.53 
acid 
Germerine Diester C37H.590llN 193-19.5 +lo.8(CHC13) Methylethyl glycolic Poethke 1932 
acid and 1-methyl-
ethyl acetic acid 
Germidine Diester C34H.530lON 220-223 +13(CHC13) Acetic acid and Fried et Methyl butyric acid al 1949 
Germini trine Triester c39H.57onN 17.5" -36.0(cl.l2 py) Acetic, tiglic and Klohs et 
+7.8(cl.3.5 in CHCl3) angelic acids al 19.53 
Germitrine Triester 039%1°1~ 216-219 -69 (pyridine) Methyl butyric, Fried et 
-4(CHC13) Methyletbyl glycolic al 1949 
and acetic acids 
Neogermitrine 234 -77.3(cl.O in py) Kupehan and 
Delewala 19.53 
- - -
V1. 
Table 2 (cont1d)-4 
&Ipirical 
Melting 
Alkaloid Type Point c~~ Formula oc Acid or Sugar Reference 
Neoprotoveratrine Tetraester 041H63°15N . 255.4- .;.39(in pyridine) Acetic (2),•metbyl- Klohs et 
255.8 butyric and ct.methyl- al 1952 
(decomp) .t.. /3 dehydrox;rbutyric 
acids 
Protoveratridine Monoester 032H51°10N 266-268 Methyletbyl acetic Salzberger 1890 
Protoveratrine Triester 039%1°13N 275-283 -9.l(CHC~ Acetic, 1-methylethyl Salzberger (decomp) -4o(pyri e) acetic and methyl- 1890 
ethyl glYcolic acids 
Pseudojervine Glycoside C33B4908N 300-307 -133(ETOH and CHCl3) D-glucose Wright and (decomp) 1:3 Luff 1879 
-139(ETOH and CHCl3) 
7:46 
Veralbidine 037~1°12N 181-183 -11.7(pyridine) Stohl and 
+5.4(CHC13) Siebeck 1952 
Veratridine Monoester C36H51011N 16o-180 +8.0(ETOH) Veratric acid Bossetti 1883 
Veratrosine Glycoside 033~9'7N 242-243 -53(ETOH and CHClJ) D-glucose Jacobs and Craig 1944 
Veratroyl- CJ6H51010N 270-271 -27(CHC1J) Kupehan and 
zygadenine (decomp) Deliwala 1953 
- --~-- ----
- - -- - - ----------- ------- --- . 
()'. 
both clinically and experimentally. Of these extracts, "Veratrone" 
and "Veriloid" have been the most widely used. "Veratrone" is an 
extract probably containing all the alkaloids and is assayed on the 
basis of total alkaloidal content by chemical means (LaWall 1897). 
"Veriloid11 contains ester alkaloids from Veratrum viride purified by 
fractionation. It is standardized by the fall of mean arterial 
pressure in dogs anesthetized with pentobarbital (Maison and Stutzman 
1951). In the present investigation it was studied in some detail; 
some of its physical and chemical properties are presented in table 3. 
The effects of veratrum on the mammalian cardiovascular system 
include bradycardia and either a fall or rise in blood pressure 
according to the dose. The pressor action is seen only when toxic 
doses are administered. The depressor and bradycardic responses have 
been shown to be reversible and have been demonstrated in a variety of 
mrumnals (rabbit, cat, dog and man) either anesthetized or unanesthe-
tized (Krayer 1946). 
At present some doubt exists concerning the exact mechanism of 
the depressor action. The decrease in arterial blood pressure might 
be brought about by (a) a relaxation of the smooth muscle of the blood 
vessels, (b) a decrease in cardiac output due to bradycardia or (c) a 
combination of (a) and (b). The effect on the blood vessels may be due 
to (a) a direct action of the drug on the blood vessels, (b) a reflex 
action or (c) a direct effect of the drug on the cardiovascular centers 
in the central nervous system. Which one or which combination of these 
mechanisms is involved in the depressor action of veratrum has not been 
7 
Table 3 
Physical and Chemical Properties of ''veriloid' * 
Appearance - pale yellotf amorphous powder 
}1.P. - sinters at 102 - 105° C 
melts at 148 - 15~ C 
260 0 
Optical rotation -~D in ETOH • - 17.3 C • o.5 G/100 m1 
u. V. absorption curve - peak at 25oO A0 lnE • 3.30 (at 0.00008 Gm/ml) 
Solubility - In H20 - very sl. sol. 
In dilute acid - very sol. 
In benzene, alcohol, chloroform, propylene glycol, 
acetone - soluble 
Spot test reaction with cone. H2so4 - dark orange going to reddish 
orange to brown in 24 hours 
Nitrogen content - 2.9% 
* From Stutzman, Maison and Kussel!'ow. Proc. Soc. for Exper. Biol. 
and Med. 71:725, 1949 
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clearly defined. 
Although the depressor and bradycardic responses to adminis-
tration of veratrum derivatives are superimposed, one must necessarily 
analyze them separately. The depressor action, being of greater 
interest, will be considered first. MacNider (1925) using "Veratrone" 
and Willson and Smith (1943) using a tincture of Veratrum viride postu-
lated a direct effect on the blood vessels. Krayer (1943, 1946) and 
Moe (1944) have offered evidence which demonstrated that the depressor 
action of small doses of veratrine, veratridine and protoveratrine 
cannot be caused by a direct action on the blood vessels. 
Numerous investigations have been undertaken to determine the 
role of the vagus nerves in the depressor effect observed after the 
administration of veratrum derivatives. The influence of bilateral 
cervical vagotomy in the rabbit was investigated by von Bezold and 
Hirt in 1867. Cramer (1915) performed similar experiments in the cat. 
These authors concluded that at least one vagus nerve was essential 
for the depressor response after intravenous injection of an extract 
of Veratrum viride. The failure of bilateral cervical vagotomy to 
abolish the depressor response to injection of a tincture of Veratrum 
viride was demonstrated by Mac Nider (1925). Willson and Smith (1943) 
using "Veratrone," also noted that sectioning of the vagus nerves de-
creased but did not abolish the fall in blood pressure. Similar results 
have been reported for the cat (Jarisch and Richter 1939). Moe, Basset 
and Krayer (1944) have reported that vagotomy decreased the depressor 
response to veratridine but rarely abolished it. Stutzman, Simon and 
9 
Maison demonstrated that bilateral cervical vagotomy in the dog anes-
thetized with pentobarbital did not quantitatively alter the depressor 
response to the intravenous infusion of any of six different veratrum 
derivatives (table 4). 
Several investigators (von Bezold and Hirt 1867, Jarisch and 
Richter 1939, Krayer 1946, Dawes 1947, Aviado and Pontius 1949, Aviado 
1951) have performed experiments to locate receptors of vagal afferents 
involved in the depressor action of veratrum. Von Bezold and Hirt 
(1867) concluded from experiments in the rabbit, that the ventricles 
were the main areas of origin of afferent impulses. Cramer (1915), 
however, was of the opinion that the pulmonar.y afferents of the vagus 
were more i..rnportant. Jarisch and Richter (1939) and Amann and Schaeffer 
(1943), using cats, concluded that the vagal afferent fibers, especially 
those located in the coronary arteries, were the main ones involved in 
the veratrum depressor action. More precise localization of the recep-
tor areas to the coronary arteries supplying the left ventricle has 
been reported by Dawes (1947) and Aviado and Pontius (1949). The 
specificity of the 11von Bezold effect" arising from the ventricles was 
questioned by Jarisch and Zotterman (1948) who looked upon it as a 
"kind of nociceptive reflex." 
Evidently, other areas than those innervated b,y the vagus nerves 
must contribute to the depressor response observed after injection of 
veratrum derivatives into vagotomized animals. A few investigators 
(Heymans and Heymans 1926, Dawes 1947, Aviado and Pontius 1949) have 
presented rather meager evidence to show that the carotid sinus area 
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Table 4 
Decrease in Mean Arterial Blood Pressure with Veratrum Alkaloids 
Before and After Bilateral Cervical Vagotomy* 
Decrease in Mean Arterial Pressure 
Alkaloid Mcg/kgm/min 
for 10 minutes ** Before Vagotomy Arter Vagotomy 
Per cent :t s.n. Per cent :t S.D. 
(mm Hg ± S.D.) (mm Hg * S.D.) 
Germitrine 0.1 and 0.125 + 35.9 • 12.7 45.2 t 16.6 
(.5o.l :!: 20) (46.2 t 16. 7) 
Germerine 0.19 30.2 t 6.3 22.8 t 9.5 (36.6 ± 10.0) (28.8 :t 14.9) 
Protoveratrine 0.2 28 t 12.2 29.8 :!: 10.4 (39.7 t 16.4) (38.9 t 24.1) 
Germidine o.4 and o.5 + 44.8 t 17.4 40.7 t 12.7 ( 55 t 14) (43.6 ± 7.9) 
Veratridine 2.0 26.6 :t 9.1 30.4 t 10.7 (38.4 ± 16.6) ) (38.8 ± 12.2: 
Veratramine 6o and 100 + 27.7 t 18.7 23.6 :t 12.8 (34.2 :t 20.2) (25.2 :!: 1o.2: ~> 
---- ~------- -----
- --- - - · - --- - ·--- .. ~- - - -- -----
*Data from the paper of Stutzman, Simon and Maison (19.5o). 
** Each figure is the averaged response for ten anesthetized dogs. 
+ Five animals tested at each dose. 
1-' 
...... 
may function to some extent in the veratrum depressor action. 
Gruhzit, Freyburger and Moe (1953} have recently reported that "The 
depressor action of "Veriloid" in dogs was abolished by section of 
the vagi and carotid sinus nerves, but not by either procedure alone." 
Recent reports (Stutzman, Simon and Maison 1951, Taylor and Page 
1951) have suggested that the action of veratrum on the central nervous 
system is the most important component of the depressor effect. Other 
investigators have also recognized the participation of the central 
nervous system in the depressor action of veratrum, put have considered 
it unimportant (Richter and Thoma 1939, Dawes 1947). Borison (1953), 
however, has reported that 11no evidence has been found for a central 
hypotensive action of nveriloid11 but that the nodose ganglia are the 
sites of the receptors originating the depressor action. The recep-
tors of the reflex producing bradycardia have also been intensively 
investigated. The vagal centers have been postulated as a possible 
site of action (Pilcher 1915, Heymans 1926, Krayer 1946). 
Much evidence indicates that the bradycardic action of veratrum 
is due to a vagal reflex (von Bezold 1867, Cramer 1915, Jarisch and 
Richter 1939, Richter and Thoma 1939, Dawes 1947, Aviado and Pontius 
1949). The carotid sinuses have also been implicated in veratrum 
induced bradycardia (Jarisch and Richter 1939, Krayer 1943, Heymans 
19.50). 
The dosage range for the production of slowing of the heart 
rate after administration of veratrum derivatives lies within that 
required to produce a depressor action. Krayer and Acheson (1946) 
12 
reported that the bradycardic effects of veratridine or protoveratrine 
were proportional to the doses employed. A difference in the brady-
cardic effects of these two was demonstrated (Krayer 1944) in that 
the latent period after administration of veratridine is a few seconds 
in contrast to 120 seconds for protoveratrine. The duration of the 
bradycardia following the latter was much longer. 
Veratrum derivatives also exhibit an antiaccelerator effect which 
has been investigated mainly by Krayer and his associates. Veratramine 
was first reported to possess this property. Intravenous injections 
prevented the cardioacceleration due to electrical stimulation of the 
peripheral ends of the sectioned accelerator nerves in the cat heart-
lung preparation. They also demonstrated that it antagonized the 
positive chronotropic action of !-norepinephrine in the spinal cat and 
in the dog heart-lung preparation. A direct relationship between 
dosage (8.5 to 85 microgm. per kgm.) and antiaccelerator response of 
veratramine was reported (Krayer, 1949). Several other veratrum 
derivatives were also investigated under similar conditions. Jervine 
and pseudojervine were shown to possess some antiaccelerator activity. 
Veratridine in doses up to 0.3 mgm. and cevine in doses up to 40 mgm. 
did not antagonize the cardioaccelerator properties of epinephrine. 
The action of veratrosine as a selective inhioitor of the positive 
chronotropic effect of epinephrine or norepinephrine was demonstrated 
by Krayer (1949). It· was sho1.m to be twice as potent as veratramine 
in the heart-lung preparation of the dog. Krayer (1950) proposed the 
hypothesis that the antiaccelerator effect of the veratrum derivatives 
13 
is due to competition between veratrtun and the sympathomimetic amines. 
Marsh (1951) studied the influence of various anesthetics on the action 
of veratramine. It was demonstrated that this effect is most pronounced 
in unanesthetized or thiopental depressed dogs, is less during pento-
barbital anesthesia, and is least during ether or sodium barbital 
anesthesia. 
Another cardiovascular effect of veratrum derivatives is a rise 
in blood pressure, which has been observed after the intravenous adminis-
tration of large doses of veratridine or protoveratrine (Watts Eden 
1892, Moe 1944, Krayer 1944). Moe (1944) and Krayer (1944) perfused 
the hind limb of the dog in experiments designed to elucidate the 
mechanism of the pressor response to large doses of veratridine or 
protoveratrine. They concluded that a humoral substance was involved 
in the pressor action. The role of epinephrine has been established 
by several methods. Krayer (1944) has reported an increase in the 
amount in the adrenal vein during the veratrum-induced pressor response; 
the content of blood samples was assayed by means of the isolated 
rabbit gut preparation. Perfusion of the adrenal gland also indicated 
that veratrine causes release of this substance (Kusnetzow 1926). The 
cardiac stimulating effects of large doses of veratrum derivatives has 
been likened to the effect seen with injection of epinephrine (de v. 
Cotton 1951). This action was reduced by adrenalectomy in animals 
anesthetized with a combination of barbital and phenobarbital. Central 
nervous system stimulation with a resultant discharge of the sympathetic 
nervous system has also been suggested as the mechanism of the pressor 
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response (von Bezold 1867, Jarisch and Richter 1939, Cicardo 1953). 
The foregoing discussion indicates the salient points of the 
controversy in regard to the cardiovascular actions of veratrum 
derivatives. It is difficult to arrive at definite conclusions as to 
the mechanism of action of veratrum derivatives from past investigations 
because of the variety of doses and techniques used. In the present 
series of experiments equidepressor doses as determined by the dog assay 
method (Maison 1951) were used (table 5). 
Interruption of impulses in sympathetic nerves either at the 
ganglia or at the nerve endings constitutes a mechanism whereby ae-
pressor effects may be produced. Although it has been shown that during 
the depressor effect of veratrum vasoconstrictor agents or stimuli 
(Cramer 1915, McNider 1925, Jarisch 1939) produced a qualitatively 
normal response, no quantitative data have been presented. A series of 
experiments was undertaken to determine whether or not veratrum possessed 
any adrenolytic or sympatholytic activity. Further experiments were 
performed to determine whether or not veratrum possessed ganglionic 
blocking activity. 
The role of the vagus nerves in the depressor action is one of the 
chief sources of. controversy in regard to the site of action of veratrum 
derivatives. Studies were undertaken in an attempt to clarify this 
problem. These included (a) sectioning of the vagus nerves, (b) cold 
block of the vagus nerves, (c) evaluation of the influence of species, 
and (d) the effect of various anesthetics on the depressor response. 
An adequate explanation of the role of the central nervous system 
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Table 5 
Doses of Veratrum Alkaloids Producing the Same Fall 
in Mean Arterial Pressure as 1 microgm. of 11Veriloid11 
per kgm. per Minute for 10 Minutes * 
Number Dosage 95% Confidence 
Alkaloid of mcg/kgm/min Limits 
Dogs 
Genuitrine 12 0.093 o.o83-o.1o6 
PNP111 18 0.094 o.o86-o.l04 
Neogermitrine 18 0.115 0.099-().136 
Gennerine 18 0.189 0.168-o.217 
Protoveratrine 49 0.211 O.l95-o.2~ 
Genuidine 18 0.415 0.364-o.483 
Veratridine 12 2.0 1.72-2.38 
Veratrine 12 3.39 2.92-4.05 
Cevadine 6 5.52 4.34-7.69 
Veratramine 24 41.6 36.7-45.0 
*Adapted from the paper of Maison, Gotz and Stutzman 
(1951). 
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in the depressor effect has not yet been reported. The cross-
cirl}ulation technique was utilized to study the effect of veratrum 
derivatives on the central nervous system; this afforded an opportunity 
to :study the effects on the peripheral vascular system. 
The effect of adrenergic blockade (dibenamine) on the pressor 
act:Lon of 11Veriloid11 was sty.died in dogs anesthetized with pentobar-
bital. 
Investigation of the bradycardic action of veratrum derivatives 
was concerned mainly with (a) a quantitative estimate of the relative 
bradycardic activity, (b) the influence of rate of administration and 
dosH, and (c) the mechanism of action. 
The effect of veratrosine on a variety of experimentally produced 
cardiac arrhythmias was also studied. 
(A) Vascular Action of Veratrum Derivatives. 
Methods (General): Veratrum derivatives were weighed in portions of 
5 t<> 10 mgm. to the nearest 0.1 mgm.. "Veriloid" was dissolved in 2 ml. 
of propylene glycol-ethyl alcohol in equal parts and then diluted to the 
proper volume with 0.9 per cent sodium chloride solution containing 0.1 
per cent acetic acid. Alkaloids were dissolved in several ml. of 5 per 
cent acetic acid and subsequently diluted to volume with 0.9 per cent 
sodj_um chloride solution and acetic acid so that the final solution con-
tained less than 0.1 per cent acetic acid. All doses were administered 
in ~L total volume of 5 ml. 
Doses of each agent capable of producing an average 30 per cent 
fall in mean arterial pressure were selected on the basis of the dog 
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assay method of Maison, Gotz and Stutzman (1951) • In general intra-
venous injection in 3 to 5 seconds of half the selected dose in anes-
thetized dogs will produce as much fall in blood pressure as will the 
full dose infused over a 10 minute period. The dose of "Veriloid11 
used was 10 microgm. per kgm. infused over a 10 minute period unless 
otherwise specified. Both rapid intravenous injections and slow 
infusions were followed by 2 cc. of 0.9 per cent sodium chloride 
solution. 
Experiments were perfor.med on unselected adult dogs, cats and 
rabbits. Anesthesia was produced by the intravenous injection of 30 
mgm. of sodium pentobarbital per kgm. Mean arterial pressure in a 
femoral artery was recorded by a mercury manometer. Intravenous in-
jections lrere made into the ipsilateral femoral vein. 
Heart rates were determined from electrocardiograms. Control 
rates were the means of 4 to 6 fifteen second observation periods 
recorded at intervals of several minutes before injection of the drug. 
The tabulated decrease in heart rate was the difference between the 
control rate and the lowest 15 second period. after administration of a 
drug. All tracings were taken using Lead II. Any deviation from these 
procedures will be described in the individual sections. 
11Veriloid11 was selected as the basis of comparison because of the 
availability of a large quantity of standardized powder. 
(a) Adreno1ytic or Sympatholytic Action of Veratrum Derivatives. 
Methods: Thirty-one anesthetized dogs were used to determine the in-
fluence of "Veriloid" on the pressor response due to intravenous injection 
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of epinephrine or 1-norepinephrine as well as to splanchnic nerve 
stimulation. 
In 10 dogs, 5 microgm. of epinephrine per kgm. were given by 
rapid intravenous injection before and during a "Veriloid"-induced 
decrease in blood pressure. Eight of these ten animals received 
epinephrine after the blood pressure had returned to control values. 
In 16 animals, 3 m.icrogm. of 1-norepinephrine per kgm. were rapidly 
injected intravenously before and during the depressor response. 
In 5 dogs, artificial respiration was given through a tracheal 
cannula and thoracotomy was performed. The left splanchnic nerve 
was freed immediately above the diaphragm. A shielded electrode was 
utilized for the application of a tetanizing current to the nerve be-
fore and during the depressor effect of "Veriloid." 
Results: Table 6 summarizes the effects of 11Veriloid11 on the vaso-
pressor action of epinephrine, 1-norepinephrine or splanchnic nerve 
stL~ulation. Epinephrine had the same effect when injected intra-
venously before (pressor response of 97 ± 19 mm. Hg.), during (pressor 
response of 126 ± 21 mm. Hg.) or after (pressor response of 101 ! 16 mm. 
Hg.) the 11Veriloid11 depressor effect as did 1-norepinephrine before 
(pressor response of 101 ± 18 mm. Hg.} and during (pressor response of 
112 ± 21 mm. Hg.) the 11Veriloid 11 effect. It was concluded that "Veriloid11 
was not an adrenergic blocking agent since it did not reduce the pressor 
effect of epinephrine or 1-norepinephrine. 
The procedure necessary for the isolation of the splanchnic nerve 
resulted in a lower control blood pressure (90 ! 18 mm. Hg.) than was 
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Table 6 
The Effects of 11Veriloidtt on the Vasopressor Action of Epinephrine 
!-norepinephrine or Splanchnic Nerve Stimulation 
(1) (2) (3) (4) (5) (6) (7) 
Vasopressor Number Control Control Nadir of Vasopressor Blood Pressure 
Stimulus of Blood Pressure Vasopressor Blood Pressure Response at After Recovery 
Animals mmHg Response After "Veriloid" Nadir nnn Hg nnnHg 
Mean & s.n. nnnHg nnnHg Mean & S.D. Mean & s.n. 
(Range) Mean & S.D. Mean & S.D. (Range) (Range) 
(Range) (Range) 
Epinephrine 10 148 ± 16 97 ± 19 103 :!: 3J 126 ± 21 ** 138 * t 22 
5 mcg/kgm (127-170) (68-130) (56-148) (87-169) (100-164) 
!-norepinephrine 16 131 ± 22 101:!: 18 90 ± 12 112 :!: 21 ** 
--3 mcg/kgm (78-126) (66-104) (6<:>-146) 
Splanchnic 5 90 ± 18 65 ± 26 70 ± 35 81 ± 39 ** 
--Nerve (66-112) (38-96) (32-126) (32-130) 
Stimulation 
* Mean of eight dogs 
*ir These values did not differ from the values in column 4 (P • o.5) 
(8) 
Vasopressor 
Response After 
Recovery 
nnnHg 
Mean & S.D. 
(Range) 
101 * t 16 
(84-134) 
--
--
~ 
seen in the previously described experiments (147.7 ! 16 and 131! 22 
mm. Hg.); however, stimulation of these nerves with a tetanizing current 
resulted in a rise of blood pressure of 65 ± 26 mm. Hg. A greater 
pressor response (81 :t 39 mm. Hg.) was obtained when the stimulus was 
applied at the nadir of the "Veriloid11 effect. It was therefore con-
cluded that 11Veriloid11 was not a sympatholytic agent since it did not 
block the effects of splanchnic nerve stimulation. 
(b) Ganglionic Blocking Action. 
Methods: The pressor effect of bilateral carotid occlusion was used 
to determine if 11Veriloidll possessed any ganglionic blocking action. 
In 12 dogs, several inches of each comrnon carotid artery were isolated. 
They were occluded for 30 seconds 0y rubber covered clamps placed with-
out pulling on the arteries before, during and after the depressor effect 
of an intravenous infusion of 11Veriloid. 11 The depressor response to 
carotid occlusion was calculated as per cent of (mean arterial pressure 
minus 60) (method of Prochnik, Maison and Stutzman 1950). 
Results: The effect of "Veriloid11 on the pressor response to bilateral 
carotid occlusion is shown in table 7. The rises in blood pressure after 
carotid occlusion during (53! 69 mm. Hg.) and after05 ± 20 mm. Hg.) 
the "Veriloid" effect were of the same magnitude as those observed 
during the control period (41 ± 27 mm. Hg.). It was concluded that 
11Veriloid11 was not a ganglionic blocking agent. 
(c) Action Mediated by the Vagus Nerves. 
(1) Influence of vagotomy in the dog. 
Methods: Twenty-five dogs were utilized to determine the effects 
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(1) (2) 
Control 
Number Blood Pressure 
of mmHg 
Animals Mean & S.D. 
(Range) 
12 136 t 19 
(100-16o) 
Table 7 
The Effect of "Veriloid" on the Blood Pressure Response to 
· Bilateral Carotid Occlusion in the Anesthetized Dog 
(3) (4) (5) (6) (7) 
% Vasopressor Nadir of % Vasopressor Blood Pressure 
Response to "Veriloid" Response to Number After Recovery 
.Carotid Occ. Hypotension Carotid Occ. of From "Veriloid n 
Mean & S.D. mmHg Mean & S.D. Animals Hypotension 
(Range) Mean & S.D. (Range) mmHg 
(Range) Mean & s.n. 
(Range) 
41*:27 97 t 16 53**: 69 6 126 :!: 22 
(14-88) (76-120) (10-140) (104-168) 
* Calculated as % of (control blood pressure minus 60) (Prochnik, Maison and Stutzman 1950) 
**These values did not differ from those in column 3 (P • o.5). 
(8) 
% Vasopressor 
Response to 
Carotid Occ. 
Mean & S.D. 
(Range) 
35 t 20 
(16;,.75) 
1\) 
1\) 
of bilateral cervical vagotomy on the depressor response to "Veriloid." 
Following a control period of at least 15 minutes during which the 
blood pressure remained constant, "Veriloid11 was administered. After 
the blood pressure and heart rate had returned to control values, 
bilateral cervical vagotomy was performed. 11Veriloid11 was repeated. 
Results: Table 8 shows the blood pressure and heart rate changes 
observed. The depressor responses in intact (32 ! 18 mm. Hg.) or 
vagotomized ( 28.5 ~ 9 imn. Hg.) animals were not significantly different 
(P Q o.5). The bradycardia, however, was abolished by vagotomy. These 
experiments demonstrate that the fall in blood pressure after "Veriloid" 
administration is not dependent upon the integrity of the vagus nerves. 
In contrast, "Veriloid"-induced bradycardia was shown to be abolished 
by section of the vagi. 
(2) Influence of cold block of the vagus nerves in the dog. 
Methods: In 20 dogs several inches of each vagus nerve were freed in 
the midcervical region and wrapped in rubber sheeting wet with 0.9 
per cent sodium chloride solution. Cold block was obtained by applying 
ice to the rubber sheeting. The effectiveness of the block was demon-
strated by stimulating the right vagus central to the block with a 
tetanizing current which before or after application of the ice pro-
duced extreme bradycardia, but during the block did not. Block was 
demonstrated prior to administration of the drug and several times 
after completion of the injection. Each dog received by intravenous 
injection lasting 3 to 5 seconds three doses of a veratrum derivative 
administered before, during and after cold block respectively. Solvent 
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Table 8 
Depressor and Bradycardia Responses to Infusion 
o:f 11Veriloid11 in Anesthetized Dogs 
(1) (2) (3) (4) (5) 
Experimental Control % Decrease Control Decrease in 
Conditions Blood Pressure Mean Arterial Heart Rate Heart Rate 
(Number of mmHg Pressure Beats/min Beats/min 
animals) Mean & S.D. Mean & S.D. Mean & S.D. Mean & s.n. 
(Range) (Range) (Range) (Range) 
Intact 120 t 18 28.~ t 9 173 :t 37 -44.6 :t 25 
Animal (96-146) (21-57) {109-230) (8-100) (25) 
Bilateral 
o** Cervical 115 :!: 2~ 32* :t 18 183 ! 35 
Vafoto:my (92-158 (15-46) (121-234) 
25) 
- -----~-----~----- ~- -----· ---- - ------ -
* These values did not differ. (P • o.5) • 
** Any change in heart rate was negligible. 
{6) 
% Decrease 
in 
Heart Rate 
Mean & s.D. 
(Range) 
24.5 t 11 (6-55) 
o** 
~ 
controls were injected into each animal at some time during the experi-
ment when the blood pressure was at control levels. Approximately two 
hours were allowed to elapse between successive injections of proto-
veratrine to allow the blood pressure and heart rate to return to control 
levels. 
Results: The results are shown in table 9. The depressor and brady-
cardic responses of the first and third injections of 11Veriloid11 were 
not significantly different (P = o.5). The same was true of proto-
veratrine. The responses before and after cold block were averaged 
because the conditions of the experiment were essentially the same 
during these injections. This mean was then compared to the results ob-
tained during cold block of the vagus nerves. The fall in blood pressure 
following administration of 11Veriloid11 during cold block of the vagus 
nerves (38.5 ± 8.5 mm. Hg.) was not significantly different (P = o.5) 
from the response observed during the control periods (49.9 ± 8.6 mm. 
Hg.). Similarly, protoveratrine administration produced a depressor 
response during cold block of the vagus nerves (30.3 ~ 16.8 mm. Hg.) 
which was not significantly different (P = 0.5) from that observed 
during the control periods (35.4 ± 7.6 mm. Hg.). After injection of 
11Veriloid, 11 the blood pressure returned to control values in 46 t 12 
minutes. After protoveratrine, 109 ± 23 minutes were required. These 
values were significantly different (P = 0.01). During cold block of 
the vagus nerves, the duration of the response to Veriloid was 43 ± 9 
minutes, and with protoveratrine it was 101 ± 18 minutes. These figures 
were not significantly different (P = 0.5) from those produced by the 
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Table 9 
-The Depressor and Bradycardic Responses to "Veriloid" and Protoveratrine 
·Before, During and After Cold Block of the Vagus Nerves of the Dog 
(.1) {2) (3) (4) (5) (6) Heart Rate After Drug 
Control 
Number Blood Pressure 
Injection .Drug of Me:&~.D. Number Animals (Range) 
(1) Control 11Veriloid" 10 125:!: 27.5 
(88-168) 
(2) Cold Block 11Veriloid11 10 130 t 13.6 
(90-164) 
(3) Control "Veriloid" 10 127 :t 24.6 
(100-158) 
(1) Control Protoveratrine 10 148 :!: 19.3 
(120-190) 
(2) Cold Block Protoveratrine 10 1.30 :t 23.2 
(104-184) 
(3) Control Protoveratrine 10 122 :t 19.5 
(94-1!50) 
Average of 11Veriloid11 10 127 ± 26 
1 & 3 (88-168) 
Average of Protoveratrine 10 135 ± 19.1!. 
1 & 3 (94-190) 
* A-V nodal rhythm ~dth frequent premature contractions 
** These values were found not to be different (P • o.5) 
+ These values were found not to be different (P • o.5) 
* Any change in heart rate was negligible. 
% Decrease 
Mean Arterial 
Pressure 
Mean & S.D. 
(Range) 
!50.7 :t 7.4 
(36-59) 
38.5** * 8.5 (23-!50) 
49.2 t 9.9 
(39-62) 
41.3 :!: 7.1 
(26-52) 
.30.3+ :t 16.8 
(15-58) 
29.6 :!: 8.1 
(18-46) 
49.9** ± 8.6 
(36-62) 
35.!r.+ :1: 7.6 
(18-52) 
Control ·(7) (8) 
Heart Rate Decrease in 
Beats/min Heart Rate % Decrease 
Mean & S.D. Beats/min Mean & s.n. 
(Range) Mean & s.D. 
(Range) 
(Range) 
169 :!: 32 -!'97.6 ± 43 oo±41 
(1.30-2.30) (25-185) (17-80) 
170 t 29.5 o* o* (l)J-235) 
165 :!: 20.6 -92.7 :!: 55 54.9 :!: 29.5 (132-210) (35-190) (22-91) 
158.5! 32 -53.9 :!: 20.5 34.3 :!: 13.2 (ll5-215) (23-97) (19-67) 
158.7 ± 26.5 o* o* (128-196) 
156 ± 27 -42.8 :!: :JJ.6* 28.3 :!: 19.3 
(105-195) (8-100) (4.4-55.5) 
167 ± 26 • .3 -94.7 ± 31 57 .!r. :!: 35 
(1.30-2'$J) (25-190) (17-91) 
157 :!: 29 -48.3 :!: 25 31.3 t 16.2 
(10.5-215) (8-100) (.5-67) 
1\) 
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same drugs in the absence of cold block. 
The bradycardia response to "Veriloid" or protoveratrine was 
abolished during cold block of the vagi. The bradycardia responses 
after administration of "Veriloid11 before and after cold block of the 
vagi (Fig. 1, first and third injections) were not significantly 
different (P = o.5). The electrocardiographic tracings of the brady-
cardia response to "Veriloid11 demonstrated a normal sinus configuration. 
The first injection of protoveratrine produced a normal sinus brady-
cardia, but after the third injection atrioventricular nodal rhythm 
with frequent ventricular premature contractions were observed in four 
of the ten dogs tested. Other diff erences between the bradycardia 
response to 11Veriloid11 and that to protoveratrine were the latency be-
fore development of, and the duration of the maximum effect. The mean 
time before maximum decrease in heart rate after rapid injection of 
Veriloid was 12 ! 3 seconds (10 dogs) while for protoveratrine it was 
45! 21 seconds (10 dogs). These figures were different (P = 0.01). 
The duration of the bradycardia was 3.4 ! 1.4 minutes after 11Veriloid11 
while after protoveratrine it was 31 ! 14 minutes. These values were 
also different (P • 0.01). 
(3) Influence of species 
Methods: These experiments were undertaken to determine the role of the 
vagus nerves of the rabbit and cat in the depressor and bradycardia re-
sponses to ''Veriloid." Anesthesia was obtained by the intraperitoneal 
injection of 35 mgm. of sodium pentobarbital per kgm. Blood pressure 
was recorded from the common carotid artery by means of a mercury mano-
meter, and the heart rate was followed electrocardiographically. 
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Figure 1 
The Depressor and Bradycardic Response of the Dog Before, 
During and After Cold Block of the Vagus Nerves. 
Blood pressure and electrocardiographic tracings of a cold 
block of the vagus in a pentobarbital anesthetized dog. Time in 
minutes is indicated along the base line. All injections were made 
over a period of 3 to 5 seconds. (A) Veriloid (10 microgm. per kgm.) 
was injected rapidly into a femoral vein at a. The electrocardiographic 
tracing a. represents the bradycardia observed after injection of 
Veriloid. (B) The right vagus nerve was stimulated for 30 seconds 
at b. Electrocardiographic tracing b. indicates the degree of brady-
cardia observed. (C) Blood pressure five minutes after the vagus 
nerves had been blocked. At c, the right vagus was stimulated above 
the block for 30 seconds. At d, Veriloid was administered intra-
venously rapidly at a dose of 10 microgm. per kgm. Electrocardiographic 
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tracing c, corresponds to stimulation of the right vagus nerve above 
the block and tracing d represents the heart rate after administration 
of Veriloid. (D) At e, the right vagus nerve was stimulated above 
the block. The EKG pattern was similar to c. (E) Blood pressure 
recording after the vagus nerves were warmed to room temperature 
and the blood pressure had returned to control value. At f, Veriloid 
at 10 microgm. per kgm. was injected rapidly into the femoral vein. 
The EKG pattern was similar to a. 
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In 8 rabbits, the depressor and bradycardi~ responses to 11Veriloid" 
were recorded. Thirty to 45 minutes later, bilateral cervical vagotomy 
was performed. The depressor nerves were left intact. 11Veriloid" was 
again infused. 
In 4 rabbits, the responses to "Veriloid11 were recorded after 
bilateral cervical vagotomy and administration of 1 mgm. of atropine per 
kgm. Injection of acetylcholine was utilized to determine the adequacy 
of atropinization (u.s.P. epinephrine method). 
The responses of 12 intact cat s to "Veriloid" were recorded; simi-
larly the responses of 12 bilaterally vagotomized cats were recorded. 
In a third group of 10 cats, the vagi and nodose ganglia were isolated 
and the effects on blood pressure and heart rate of electrical s timula-
tion above and below the ganglia were recorded. The vagus nerves were 
then sectioned above the nodose ganglia and "Veriloid11 was administered. 
In the fourth series of 5 cats, 1 mgm. of atropine per kgm. v.ras adminis-
tered 1.5 minutes prior to the injection of 11Veriloid. 11 The adequacy of 
the atropinization was tested by the intravenous injection of acetyl-
choline (10 to 20 microgm. per kgm.). In the fifth group of 4 intact 
cats, 3 doses of 11Veriloid11 were given at hourly intervals. Finally, 
in 4 bilaterally vagotomized cats 2 hourly injections of 11Veriloid11 were 
made. In all experiments on cats, one hour following surgical manipula-
tion was allowed for stabilization of blood pressure before administration 
of 11Veriloid. 11 
Results: The results for the rabbit are shown in table 10. The blood 
pressure response of the intact rabbits (34 :!: 17 :mm. Hg.) was comparable 
to that in other species (dog 28 • .5! 9 mm. Hg. and cat 41.1 ± 16.5 mm. Hg.). 
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(1) 
Experimental 
Conditions 
(Number of 
animals) 
.Intact 
Animal 
(8) 
·Bilateral 
Cervical 
Vagotomy 
(8) 
Vagotomy 
& 
Atro)ine (8 
Table 10 
Depressor and Bradycardic Responses to Infusion of 
11Veriloid11 in Anesthetized Rabbits 
(2) .(3) (4) (5) 
Control % Decrease Control Heart Rate 
Blood Pressure Mean Arterial Heart Rate · After 11V eriloid 11 
rmnHg Pressure Beats/min Beats/min 
Mean & S.D. Mean & S.D. Mean & S.D. Mean & S.D. 
(Range) (Range) (Range) (Range) 
116 ± 16 .34* :t 17 272 ± 17 225** t 51 
(92-132) (21-73) (230-320) (120-280) 
109 ! 13 42* t 14 249 ! 36 209** ± 5o 
(86-130) (24-72) (210-320) (150-280) 
113 ± 28 31* ± 6.5 261 :!: 30 211** ± Bo 
(74-138) (22-54) (230-300) (ll0-300) 
- ----· - - · -- --
* These values were found not to be different (P .. 0.5). 
** These values were not different (P = 0.2) from those in column 4. 
(6) 
Decrease in 
Heart Rate 
Beats/min 
Mean & S.D. 
(Range) 
. -47 ± 43 
(10-135} 
+ 
-40 - 22 
(o-65) 
+ 
-SO - 51 
(0-120) 
" 
\.v 
1-' 
Bilateral cervical vagotomy in the rabbit effected no change (42 ! l4 
mm. Hg.). The heart rates after 11Veriloid11 in the intact rabbit (225! 
51 beats per min.), vagotomized (209 t 50 beats per min.) as well as the 
vagotomized and atropinized rabbit (211 ! 80 beats per min.) were not 
different (P = 0.2) from the rates during the control periods (272! 17, 
249 t 36 and 261! 30 beats per minute respectively). 
The results of the cat experiments are show in table 11. The 
depressor response to the injection of 11Veriloid" in the intact cats 
(41.1 t 16.5 mm. Hg.) was in the same range as other species. The 
depressor response after bilateral cervical vagotomy (30.4 ! 14 mm. Hg.) 
was not significantly different (P = 0.5) from that observed in the in-
tact animal. The site of vagal section did not influence fall in blood 
pressure since the response after bilateral cervical vagotomy (30.4 ! l4 
mm. Hg.) was essentially the same (P = o.5) as that observed after section 
above the nodose ganglia (27.5! 13.5 mm. Hg.). 11Veriloid11-induced 
bradycardia in the cat was abolished by vagotomy. The response to hourly 
injection of "Veriloid" decreased successively in the 4 intact cats. The 
difference in mean response to the first (45 t 6 mm. Hg.) and third (27 
± 4 mm. Hg.) was significant (P = 0.02). In the four vagotomized cats, 
the second response (7.8! 10 mm. Hg.) differed from the first (23 t 4.4 
mm. Hg.) (P = 0.01). Thus tachyphylaxis can be demonstrated in intact 
and in vagotomized cats. 
The depressor and bradycardic responses to infusion of 11Veriloid11 
. 
in the intact and in the vagotomized dog were presented in table 8. 
The depressor responses produced by the first injection of 11Veriloid 11 
were not different in the rabbit, cat and dog, nor were the responses to 
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(1) t2) 
Animal Experimental 
Numbers Conditions 
l to 12 Intact 
Animal 
13 to 24 Cervical 
Vagotomy 
25 to 34 Vagotomy above 
Nodose 
Ganglia 
35 to 40 Nodose ganglia 
removed and 
carotid bifur. 
denervated 
41 to 45 Atropinized 
Table 11 
. Depressor and Bradycar<ilic Response to Infusion of 
11V.eri1oid" in Anesthetized Cats 
(3) (4) (5) (6) 
Control % Decrease Control ·Heart Rate 
Blood Pressure Mean Arterial ·Heart Rate ·After "Veri1oid" 
IIUilHg Pressure Beats/min Beats/min 
Mean & S.D. Mean & S.D. Mean & s.n. Mean & S.D. 
(Range) (Range) (Range) (Range) 
--·· 
149 :!: 33 41.1:!: 16.5 218 t 21 145:!: 35 
(114-224) (8-58) (175-250) (100-195) 
150 :t 39 30.4 ± 14 208 :t 19 209 : 20 
(112-226) (15-56) (170-240) (170-240) 
-. 
148 : 29 27.5 : 13.5 216:!: 34 215 : 32 
(108-190) (8-50) (16o-250) (16o-250) 
135 :!: 10.5 23.5 :t 9 192 :!: 19.L. 192 ± 19.4 
(122-149} (12-39) (170-216) (170-216) 
120 :!: 13 22 t 5.6 166 ± 46 167 ± 37 
(98-132) (15-.30) (95-210) (105-210) 
- - ----- - -
(7) 
·Decrease in 
Heart Rate 
Beats/min 
Mean & S.D. 
(Range} 
+ 
.-73 - 32 
(15-110) 
0 
0 
0 
0 
w 
w 
Table 11 (cont1d) 
(1) (.2) (3) (4) (-5) (6) (7) 
Control % Decrease Control Heart Rate Decrease in 
Animal kperimental mood Pressure Mean Arterial Heart Rate After 11Veriloid11 Heart Rate 
Numbers Conditions mm.Hg Pressure Beats/min Beats/min Beats/min 
Mean & S.D. Mean & S.D. Mean & S.D. Mean & S.D. Mean & S.D. 
(Range) (Range) (Range) (Range) (Range) 
46 to 49 Intact 141:!: 21 45:!: 6 202 ± 30 128 ! 26 -74:!: 18 
Animal (122-170) (38-52) (175-245) (170-230) (70-95) 
Injection 
122 ! 10 32 :!: 6.5 196:!: 24 135 :!: 25 + Repeated -63 - 17 
1 Hour Later (110-130) (24-40) (180-230) (100-160) (40-80) 
Injection 
126 ± 27 191 ± 27 135:!: 31 -56! 15 Repeated 27:!: 4 
1 Hour Later (100-164) (24-32) (170-230) (95-170) (35-75) 
50 to 53 Vagotomized 14o :.1: 43 23 t 4.4 199 :!: 22 199 :!: 22 0 
Animal (100-200) (18-28) (170-220) (170-220) 
Injection 
131 t 38 7.8:!: 10 Repeated 19.5 ± 25 205 ± 18 0 
1 Hour Later (90-180} (0-22) (160-220) (lBo-225) 
-- - -
---~---- - -- ---
~ 
the first injection influenced by prior vagotomy. 
(4) Influence of various anesthetics 
Methods: For the determination of their influence on the effects of 
11Veriloid, 11 five commonly used anesthetic agents were studied. The 
methods for pentobarbital anesthesia were previously described. In 
this section, ether, chloralose, Dial-urethane and morphine sulfate 
will be considered. 
In 10 dogs, third plane surgical anesthesia was produced with 
ether by the open drop method and was maintained using a Wolff bottle 
connected by a tracheal cannula. 11Veriloid11 was infused and the de-
pressor and bradycardic responses recorded. One hour later, both vagus 
nerves were sectioned in the neck and "Veriloid" was again administered. 
In another 10 dogs, 6o mgm. of alpha chloralo;e per kgm. was admin-
istered intravenously. 11Veriloid11 was given one hour before and one 
hour after bilateral cervical vagotomy. 
A third group of 10 dogs was anesthetized by the intravenous 
injection of 0.5 cc. of "Dial-urethane" per kgm. Further procedures 
were the same as in the preceding group. 
The fourth series of ten dogs received 5 mgm. of morphine sulfate 
per kgm. intravenously. Sterile water was injected into the region of 
the femoral blood vessels to produce local anesthesia, and S minutes 
later the vessels were freed. Blood pressure and heart rate were re-
corded as previously described. 11Veriloid" was then infused intra-
venously. Sectioning of the vagus nerves was not attempted in these 
animals. 
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Results: The data from these groups of dogs are presented in table 12. 
It is evident that the anesthetic did not influence the depressor re-
sponse to "Veriloid" either before or after vagotomy. The bradycardic 
responses during pentobarbital, alpha chloralose or Dial-urethane anes-
thesia were not different. That seen with ether was significantly less 
(P • 0.01). The dogs which received morphine sulfate exhibited control 
heart rates which were significantly less (P = 0.01) than those ob-
served with the other anesthetic agents. The absolute decrease in heart 
rate was also less than the other groups, but the per cent decrease was 
not significantly different (P = 0.5). 
Bilateral cervical vagotomy in the animals anesthetized with pento-
barbital, ether, alpha chloralose or Dial-urethane, did not signifi-
cantly alter the depressor response to infusion of "Veriloid." In all 
cases, however, vagotomy abolished the bradycardic response. 
(5) Effect of bilateral extirpation of the carotid bifurcation alone 
or combined with vagotomy. 
Methods: "Veriloid11 was infused into 10 pentobarbital anesthetized 
dogs and the blood pressure response was recorded. Approximately one 
hour later, bilateral extirpation of the common carotid bifurcation was 
performed by ligation of the common, external, and internal carotid 
arteries and surgical removal of the intervening portion. "Veriloid" 
was again infused. 
In 21 dogs anesthetized with pentobarbital, after the depressor 
response to intravenous 10 minute infusion of 11Veriloid11 had been re-
corded, bilateral extirpation of the carotid bifurcations and bilateral 
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(1) 
Anesthetic 
(Dose) 
Sodium 
Pentobarbital 
' (30 mgm/kgm) 
Ether 
(Inhalation) 
Alpha 
Chloralose 
( 6o mgm/kgm) 
Dial-Urethane 
(0.5 cc/kgm) 
Morphine Sulfate 
(5 mgm/kgm) 
Sodium 
Pentobarbital 
(30 mgm/kgm) 
Ether 
(Inhalation) 
Alpha 
Chloralose 
( 6o mgm/kgm) 
Dial-Urethane 
(0.5 cc/kgm) 
-
~able 12 
~he Influence of Various Anesthetics on "Veriloid" - Induced 
Depressor and Bradycardic Responses in the Dog 
(2) (3) (4) (5) 
Control Control 
Experimental IUood Pressure % Decrease of Heart Rate 
Conditions mmHg Blood Pressure Beats/min 
(Number of Dogs) Mean & S.D. After "Veriloid" Mean & S.D. 
(Range) (Range) 
Intact Anllnal 120 ± 18 28.5 ± 9.5 173 :!: 37 
(25) (96-146) ' (21-57) (109-230) 
Intact Animal 131 ± 28 25 :t 8 183 :t 18 
(10) (92-170) (15-38) (170-215) 
37 t 12 111 ± 26 Intact Animal 150 ± 27 
(10) (96-196) (19-55) (Bo-16o) 
Intact Animal ~7 t 17 27.3 :t 7.5 124 :!: 24. 
(10) (130-180) (18-38) (100-1&:l) 
Intact Animal 158 t 24 23.6 :!: 9 00 :t 13 
(10) (120-195) (10-38) (45-85) 
Vagotomized Animal 115 :!: 25 32:!: 18 187 t 35 
(25) (92-158) (15-46) (121-234) 
Vagotomized Animal 140 :!: 24 22 :t 8 187 :t 22 
(10) (90-18o) (7-28) (16o-2))) 
Vagotomized Animal 
(10) 157 :!: 25 (112-188) ~ ± 15.3 17-67) 176 ± 36.6 (110-200) 
Vagotomized Animal 162 :t 28 27.3 :t 12 ~51± 28 
(10) (104-186) (14-55) (110-190) 
(6) (7) 
Decrease in % Decrease in 
Heart Rate Heart Rate 
Beats/min Beats/min 
Mean & s.n. Mean & S.D. 
(Range) (Range) 
44.6* :t 25 24.5 t 11 
(8-100) . (6-55) 
15~~ :t 9 8.3 :!: 4.2 
(0-25) (0-13) 
33.5 ± 19 30 ± 15 
(10-80) (13-63) 
37~5:!: ~ 29.3 :!: 18 
(5-80) (5-59) 
11~5* :!: 12 17:!: 15 
(0-40) (0-47) 
o+ o+ 
0 o+ 
o+ o+ 
o+ o+ 
* These values were significantly different (P = 0.01) 
** The heart rate response in dogs anesthetized with ether was signi ficantly different (P • 0.01) from that observed in 
dogs anesthetized with sodium pentobarbital, alpha chloralose or Dial-urethane. 
+ Any change in heart rate was negligible. ~ -..J 
cervical vagotomy were performed. 11Veriloid11 was again administered. 
Results: The depressor responses to infusion of 11 Veriloid11 before and 
after bilateral extirpation of the common carotid bifurcations are pre-
sented in table 13. The depressor response to administration of 11Veri-
loid11 was not reduced by bilateral extirpation of the cormnon carotid 
bifurcations. The conclusion was therefore reached that the receptors 
in the region of the carotid bifurcation play little if any role in the 
depressor action of 11Veriloid. 11 
Table 14 contains the results observed in response to the infusion 
of 11Veriloid11 before and after bilateral extirpation of the cormnon carotid 
bifurcations combined with bilateral cervical vagotomy. The mean arterial 
pressure (171 ± 21 mm. Hg.) rms higher than before (142 t 19 mm. Hg.) 
the denervation was performed. Bilateral extirpation of the common 
carotid bifurcations combined with bilateral cervical vagotomy did not 
significantly (P = 0.3) alter the depressor response to 11Veriloid11 
(34.8 t 13 mm. Hg. compared to 21 ~ 16.5 mm. Hg.). Thus, the integrity 
of the nerve fibers associated with the common carotid bifurcations and 
those of the vagus nerves in the dog is not essential to the production 
of the 11Veriloid11-induced depressor response. 
(d) Action mediated ey the cent!al . n~rv~_us sys t em. 
Met hods: The method f or these cross circ,ilation exper iments i s modified 
after t hat of Heymans and Heymans (1926). Pentobarbital was the anes-
thetic. The femoral blood pressures of the r ecipient and the donor dog 
were recor ded by means of mercury manometers. The common carotids of 
both dogs were isolated, ligated and cut; the distal ends of the recipient 
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(1) 
Number 
of 
Dogs 
10 
Table 13 
Effect of Bilateral Denervation of the Carotid 
Bifurcation on the Depressor Action of "Veriloid11 
Before Denervation After Denervation 
10 mcg/kgm infused 10 mcg/kgm infused 
over a 10 ~. period over a 10 .min. period 
(2) (3) (4) (5) 
Control % Decrease in Control % Dec.rease in 
Blood Pressure Blood Pressure Blood Pressure Blood Pressure 
mm Hg Mean & S.D. mmHg Mean & S.D. 
I1ean & S.D. (Range) 
(Range) 
Mean & S.D. (Range) 
(Range) 
140 ± 18 31 t 8 119 :t 24 40* t 17 
(121-170) (24-45) (156-220) (6-52) 
* This value did not differ from that in colmnn 3 (P • o.5). 
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(1) 
. 
N umber 
of 
Dogs 
21 
Table 14 
Effect of Bilateral Extirpation of the Common 
Carotid Bifurcation Combined with Bilateral Cervical 
Vagotomy on 11Veriloid" Depressor Action 
Before Nerve Section After Nerve Section 
10 mcg/kgm infused 10 mcg/kgm infused 
ever a 10 min. period over a 10 min. period 
(2) (3) (4) ' (5) 
Control % Decrease in Control % Decrease in 
Blood Pressure ·Blood Pressure Blood Pressure Blood Pressure 
mmHg Mean & S.D. mmHg Mean & S.D. 
Mean & S.D. (Range) l"lean & S.D. (Range) 
(Range) (Range) 
142 ± 19 .J4.B* ± 13 171! 21 21* :t 16.5 
(119-192) (21-57) (120-232) (0-50) 
*These values did not differ (P = 0.3). 
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were connected by tubing to the proximal ends of the donor 1 s arteries. 
The heart rate of the recipient dog was recorded. Artificial respiration 
was administered by respirator. After circulation to the recipient 
head had been established, the recipient's brachia-cephalic and left 
subclavian arteries were ligated close to the aorta. The spinal cord 
and all nerves of the recipient dog were left intact. Venous drainage 
from the recipient head was collected in a glass container by means of 
a cannula inserted in the superior vena cava. At intervals of several 
minutes this container of blood was emptied into a reservoir which 
returned the blood to the donor dog at a constant rate. llParitol" 
10 mgm. per kgm. was used as an anticoagulant in the donor dog. 
Injection of test substances into the recipient head liaS made 
directly into the tubing inserted into the common carotid arteries. 
Injection into the recipient's body was by way of a venous cannula in 
the femoral vein. Doses to the head were calculated in terms of the 
total kgm. of body weight of the recipient dog but were permitted to 
pass through the head only once. Injections were made over a 15 second 
period. 
As a test of the isolation of the recipient head, six experiments 
were performed in which five microgm. of !-norepinephrine per kgm. were 
injected into the head circulation and the blood pressure response of 
the body was recorded. The minimal dose of !-norepinephrine in the 
femoral vein required to produce a rise in blood presstiTe in the re-
cipient's body was similarly determined. 
To determine the role of the carotid reflex in the depressor and 
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bradycardia actions of veratrum deriva.tives, nine experiments were per-
formed in 1vhich the common carotid bifurcations ~.;ere denervated. 
These were compared with S experiments in which the innervation was 
intact. 
For removal of vagal influences, atropine in a dose of 1 mgm. 
per kgm. was administered in 21 experiments and vagotomy was utilized 
in the remainder. In the atropinized dog, 10 microgm. of acetylcholine 
per kgm. were administered into the body circulation as a test of 
atropinization. 
Blood draining from the recipient head was discarded for several 
minutes after administration of any veratrum derivative to the head. 
This procedure was used to minimize any effect on the blood pressure 
of the donor dog as well as to minimize any leakage from the recipient 
head into the recipient's body. Thus the feeding pressure to the 
head was kept constant. 
Results: Administration of 5 microgm. of !-norepinephrine per kgm. 
to the recipient head produced an average mean arterial pressure de-
crease of 25! 7.6 per cent in the recipient's body. No change in 
heart rate t~s observed. Injection of 0.05 microgm. of !-norepinephrine 
per kgm. into the body circulation produced an average increase in mean 
arterial pressure of 9.3 (± 4.1) per cent. Thus no appreciable leakage 
was evident. 
Table 15 summarizes the data for the experiments in which 11Veriloidtt 
was used. The blood pressure response to 5 microgm. per kgm. adminis-
tered into the head in dogs with the common carotid bifurcation denervated 
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(1) (2) 
Injection Number 
Confined tot of 
Expts. 
--~- ~ _____ .., . ... 
~ .. ~····' ,, """'-..: · ~ "-'" · --··-·-- ·-· · .·---·. 
Head 
(a) Common 9 
Carotid Bifurca-
tions Denervated 
(b) Common 
Carotid Bifurca- 5 
tion Innervation 
Intact. 
Body 14 
Head--after atro- 6 (3) 
pine to body 
(3) 
Body--after atro- 8 
pine 
Body--after bilat- 3 
eral vagotomy 
Table 1.5 
Cardiovascular Action of 11Veriloid" When Confined to 
Head or Body Circulation 
(3) (4) {5) (6) 
Control % Decrease in Duration of 
Dose Mean Arterial Mean Arterial Response in 
mcg/kgm Pressure Pressure Minutes 
given over a mmHg Mean & S.D. Mean & S.D. 
1.5 sec. period Mean & S.D. 
(Range) 
(Range) (Range) 
. " - .. , ... ·--··. ·- . ·-· .. . --~~,. - -· .. , . _, ..... ... 
. -- ~" ·= ~ --- -... . . ..... .. _.,., . .,_ ·-- ··"' ·- ' .... .. . ... ... ,_ .r• .·.,.- ' . ..... •• • .. ~ ••. ,_.,, ___ • ...,......., • 
; 119:!: 27.4 21.2 :!: 15 • .3 .3 • .5±1.7 (115-180) (7-46) (2-8) 
5 88 : 2.3 18.6 :!: 5 1.6 t o.6 (80-92) (14-26) (1-4) 
.. 
5 126 ± 27.2 33.7 t 9.3 10.7 ± 2.8 (120-1.55) (19-43) (7-1.5) 
5 100 t 9.4 13.9 :!: 2.4 3.7 ± 1.1 (92-13.5) (11-15) (3-7) 
10 123 t 10.6 17.2 :t 4.4 5. 7 ± 1.1 (88-130) (14-27) (4-7) 
5 118 ± 8.o 
* --(80-164) 
5 64 t 4.2 * --(6o-68) 
* Any fluctuation in blood pressure was negligible. 
** Any change in heart rate was negligible. 
(7) {8) 
eontrol Heart Rate 
Heart Rate Response 
Beats/min Beats/min 
Mean & S.D. Mean & s.n. 
(Range) (Range) 
.. . .. .., - '-~ ... -.... .. -- ·- ... -- . .... 
171 t 8.3 
** (130-190) 
1.52 ± 11.5 
** (lk0-200) 
15.5 ± 14.4 -38.8 ± 5.5 (120-190) (22-48) 
156 • 6.6 
** (150-210) 
133 :!: 6.6 
** (128-180) 
-· 
161 ± 41 
** (11.5-240) -
173 :t 10.6 *->'t (16o-180} 
e; 
(21.2 t 15.3 nun. Hg.} was not different (P = o.5) from that obtained 
in the experiments in which the nerves were left intact (18.6 t 5 mm. 
Hg.). Thus the centrally mediated depressor action would not seem to 
depend on afferents from the common carotid bifurcation. The depressor 
response observed after administration into the head lasted for 3.5 t 
1. 7 minutes. No change in heart rate of the recipient's body was ob-
served in either set of experiments. 
When 5 microgm. of 11Veriloidtt per kgm. were administered to the 
body of the recipient dog, a decrease in blood pressure (33.7! 9.3 mm. 
Hg.} and a marked decrease in heart rate (33.8 t 5.5 beats per minute) 
were observed. Administration of 1 mgm. of atropine per kgm. to the 
body did not alter the blood pressure response to injection of "Veriloid11 
into the head. No change in heart rate was observed, although a de-
crease in blood pressure occurred (13.9 t 2.4 mm. Hg.). 
Injection of 5 microgm. of "Veriloid" per kgm. into the body pro-
duced no change in blood pressure or in heart rate either after 1 mgm. 
of atropine per kgm. or after bilateral cervical vagoto~. 
In three experiments, 11Veriloid11 was administered to the head by 
constant infusion at a rate of 1 microgm. per kgm. per minute. A mean 
decrease of arterial pressure of 28.3 (t 10.4) per cent was observed 
during and for 3 to 8 minutes after cessation of infusion. 
Table 16 contains the results of experiments in which the test 
drug was protoveratrine. The results were similar to those with 
ttVeriloid." The one difference was that increased doses were necessary 
to produce a significant response when injected into the body. 
~able 16 
Cardiovascular Action of Protoveratrine When Confined to 
· Head* or Body Circulation 
(1) (2) (3) (4) 
Qontrol 
Dose ~ean Arterial 
Number mcg/kgm Pressure 
Injection of given over a Mean & S.D. 
Confined to: Expts. 15 sec. period nnnHg 
(Range) 
Head 6 1.15 94 :!: 9.4 
(84-110) 
Body 14 (6) 1.15 91:!: 23 
(66-132) 
(8) 2.2 127.7 :!: 32 
(8o-194) 
·Head-after 8 2.2 106 t 36.5 
a tropine to body (62-166) 
Body-after 7 2.2 123 t 25.5 
atropine (82-156) 
Body-after 
85· ! 14.7 bilateral cervical 4 1.15 
vagotomy (76-100) 
* Nerves to common carotid bifurcations were intact. 
+ Any fluctuation in blood pressure was negligible. 
* Any change in heart rate was negligible. 
~-
(5) 
% Decrease in 
Mean Arterial 
Pressure 
Mean & S.D. 
(Range) 
21.3 :!: 11.4 
(7-37) 
6.6 :!: 6.5 
(0-18) 
25.7 t 11.2 
(11~36) 
20.9 :!: 9.6 
(11-31) 
+ 
+ 
- - -
(6) 
Duration of 
Response in 
Minutes 
Mean & S.D. 
(Range) 
3.4 :!: 1.1 
(3-8) 
+ 2.3 - 2.0 
(1.5-5) 
7.2:!: 4.9 
(4-14) 
3.9 t 1.4 
(2-9) 
--
--
(7) 
Control 
Heart Rate 
Beats/min 
Mean & S.D. 
(Range} 
147 :!: 19.5 
(120-180) 
145:!: 14.8 
(120-200) 
168 :!: 28.5 
(140-220) 
193 :!: 39.5 
(16o-2))) 
190 :!: 36 
(15o-240) 
195 :!: 22.5 
(180-2.30) 
(8) 
Heart Rate 
Response 
Beats/min 
Mean & S.D. 
(Range) 
* 
-5.0 t 4.2 
(0-6) 
-6o:!: 17.5 
(16-55) 
t 
* 
* 
~ 
\J1. 
Table 17 presents the results of the experiments in which veratri-
dine was utilized. Veratridine differed from nveriloid" or protovera-
trine only in that veratridine produced a decrease in heart rate and 
a depressor response when administered to the body after atropine. 
In table 18 are the data for the experiments in which veratramine 
was used. This agent produced a decrease in heart rate (16 ! 5 beats 
per minute) and a depressor response (12.9 t 3.3 mm. Hg.) when adminis-
tered to the body after vagotomy. Injection of veratramine into the 
head after vagotomy was not accomplished because the blood pressure 
of the body remained low after repeated administration of the drug to 
the body. Four of the six dogs in which veratramine was restricted 
to the head showed transient convulsive movements of the body. This 
was not observed when veratrarnine was confined to the body. 
These results show that the substances fall into two groups. The 
first group when administered to the body slowed the heart and lowered 
the blood pressure after atropine or vagotomy (veratridine or veratra-
mine); the second group had no visible effect in the body after atro-
pine or vagotomy (protoveratrine or "Veriloid"). 
None of these agents produced slowing of the heart when isolated 
to the head. Thus t he bradycardia f rom all four agents requires that 
the drug reach the body. All the agents produced a fall of blood 
pressure when isolated to the head. Injections of solvents alone did 
not produce this effect. It was concluded that veratrum derivatives 
may lower blood pressure by an action on the central nervous system. 
In the case of the potent depressor agents ( 11Verlloidtl and protoveratrine) 
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(1) (2) 
Injection Number 
Confined to: of 
Expts. 
Head 3 
Body 6 
Body--after atro- 6 
pine 
Head--after atro- 6 
pine to body 
Table 17 
Cardiovascular Action of Veratridine 'When Confined 
to Head* or Body Circulation 
(3) (4) (5) (6) 
Control % Decrease in Duration of 
Dose Mean ArteriaJ. Mean ArteriaJ. Response in 
mcg/kgm Pressure Pressure Minutes 
given over a Mean & S.D. Mean & S.D. DUllHg 
15 sec. period Mean & S.D. (Range) (Range) 
(Range) 
10 139 ± 6 40 ! 8.8 5.5 :!: 1.9 
(132-145} (30-46) (4-9) 
10 101:!: 5.6 41.6 ± 6.6 1.2 ± o.8 
(94-110) (36-54) (6-9) 
10 + 91 - 3.3 10 :!: 9.5 1.6 :!: 2.8 (86-98) (4-22) (0-7) 
10 100 :!: 13.4 23 :!: 10.5 3.3 :!: 2.4 
(90-126) (16-36) (2-8) 
~ ~ --- - - - - ~ -~--- ~---~-~1.. 
* Nerves to common carotid bifurcations were intact. 
*"* Any change in heart rate was negligible. 
(7) 
Control 
Heart Rate 
Beats/min 
Mean & s.n. 
(Range) 
137 ± 25.5 
(100-158) 
154 ! 12 
(120-172) 
150 ! 49 
(100-180) 
148 :!: 44.8 
(110-200) 
(8) 
Heart Rate 
Response 
Beats/min 
Mean & S.D. 
(Range} 
** 
-98 ! 12 
(70-120) 
-16 :!: 4.6 
(8-20) 
** 
.r=-
-.J 
(1) (2) 
Injection Number 
Confined to: of 
Expts. 
Head 6 
Body 6 
Body--after 6 
.. 
vagotomy 
Table 18 
Cardiovascular Action of Veratramine When Confined 
to Head* or Body Circulation 
(3) .(4) {5) (6) 
Control % Decrease in Duration of Dose Mean Arterial Mean Arterial Response in 
mcg/kgm Pressure Pressure Minutes given over a nnnHg Mean & S.D. Mean & S.D. 15 sec. period Mean & s.n. (Range) (Range) 
(Range) 
104 109 :t .32 11.4:!: 2.7 2.9 t 1.1 
(70-154} (6-14) (2-6) 
104 + 92 - 25.8 22.1 :t 5.8 
** (62-126) (14-.30) 
104 92 t 25 12.9 :!: .3.3 
** (70-132) (8-17) 
* Nerves to common carotid bifurcations were intact. 
** Blood pressure and heart rate did not return to control values in these experiments. 
+ Any change in heart rate was negligible. 
(7) 
·Control 
Heart Rate 
Beats/min 
Mean & S.D. 
(Range) 
187.5 ! 28.5 (1.35-220) 
185.8 :!: .37 (1.35-220) 
116.7 ! 2.3.5 
(80-140) 
.(8) 
Heart Rate 
Response 
Beats/min 
Mean & S.D. 
(Range) 
+ 
+ 
-.34 - 4.8 
(20-60) 
-16 :!: 5.0 (10-20) 
~ 
co 
fall of blood pressure after injection into the body was apparently 
dependent on cardiac slowing and was eliminated by atropine. Even 
with the agents capable of eliciting fall of blood pressure when 
administered to the body after vagotomy, the depressor response was 
associated with bradycardia. It was therefore concluded that brady-
cardia must be present for the production of a depressor response when 
veratrum derivatives are confined to the body circulation of the dog. 
The data show that "Veriloid11 and protoveratrine are not locally act ing 
dilators. There remains a possibility that veratramine and veratridine 
may act locally, but the evidence is also compatible with the hypothesis 
that the fall of pressure on corporeal administration is entirely 
secondary to bradycardia. 
One other difference betrreen the agents was the convulsant action 
of veratramine. The present experiments indicated that this is central. 
(e) Pressor action of "Veriloid11 
Methods: Eight dogs were anesthetized and blood pressure recorded. 
"Veriloid, 11 200 microgm. per kgm. (L.O times the dose used in previous 
rapid injections) was injected (3 to 5 seconds) by the intravenous 
route. Approximately 90 minutes later the same dose was repeated in 
3 of the 8 dogs. After the blood pressure had returned to control 
levels, an adrenergic blocking agent (4 mgm. of dibenamine per kgm.} 
was given by slow intravenous infusion. The adequacy of the adrenergic 
blockade was ascertained by the rapid intravenous injection of from 
5 to 10 microgm. of epinephrine per kgm. The dose of "Veriloid" was 
repeated. 
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Results: Table 19 contains the results of the experiments concerned 
with the pressor action of 11Veriloid. 11 In the intact animal an increase 
in blood pressure of 120 (± 29) mm. Hg. was observed. The second in-
jection in 3 dogs gave responses which fell within the same range. 
After adrenergic blockade, an equal dose of 11Veriloid11 produced only 
a depressor effect. It was concluded from these experiments that the 
pressor effect of large doses of 11Veriloid11 in the dog is probably due 
to the r elease of epinephrine. 
(B) Cardiac Action of Veratrum Derivatives 
Methods (General): The bradycardic action of veratrum derivatives was 
studied in both unanesthetized and anesthetized dogs. Control heart 
rates were calculated as the means of the rates during 4 to 6 fifteen 
second periods taken at intervals of several minutes before injection 
of any drug. Continuous electrocardiograms were taken during the period 
extending from 15 seconds before injection to at least 2 minutes after 
completion of the injection. Thereafter, tracings were taken during 
at least one 15 second period out of each minute for 15 minutes. Lead 
II was used in all the experiments. Any displacement of the pacemaker 
from .the sino-atrial node was considered as an arrhythmia. 
(a) The bradycardic activity of several veratrum derivatives 
(1) Rapid intravenous injection 
Methods: "Veriloid11 (5 microgm. per kgm.) was injected in 3 to 
5 seconds into 6o pentobarbital anesthetized dogs. The pure alkaloids 
were administered to 20 to 24 animals with the exception of germidine 
which because of a limited supply was given to only 10. Doses of pure 
Table 19 
Pressor Action of "Veriloid11 in Anesthetized Dogs 
First injection of Second injection* of Injection of 
200 mcg/kgm given 200 mcg/kgm 200 mcg/kgm given over a 
over a 3 to 5 second given over a 3 to 5 3 to 5 second period after 
~umber period second period Adren. Blockade (Dibenamine) 
. 
of 
Animals Control I:tise in Control Rise in 9ontrol Fall in 
Blood Pressure Blood Pressure Blood Pressure Blood Pressure Blood Pressure Blood Pressure 
nnnHg mmHg nnnHg DDUHg nunHg mmHg 
Mean & S.D. Mean & s.D. Mean & S.D. Mean & S.D. 
{Range) (Range) (Range) (Range) 
8 127 ! 37 120 :!: 29 120 58 90.7 t 29 41:!: 43 
(76-168) (82-164) 108 300 (68-14o) (6-140) 
96 96 
* Only 3 animals received a second injection before adrenergic blockade (Dibenamine). 
\.11 
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alkaloids were equivalent in depressor effect to 5 microgm. of "Veriloid" 
per kgm. Six of the purified veratrum alkaloids and 11Veriloid" were 
injected into 5 dogs each at one and one half times the dose. 
The bradycardic response to the administration of veratrum deriva-
tives may be expressed as minus beats per minute or as per cent decrease 
in heart rate. Since it has been observed (Maison and Stutzman 1951), 
that there exists a preferred method of expressing depressor responses 
(per cent decrease), it was decided to determine which if either of the 
two methods of expressing the bradycardic response would be the more 
useful. Fifty-five cases of infusion of 11Veriloid11 (10 microgm. per 
kgm. infused over a ten minute period) in dogs were collected from the 
above described experiments and were plotted on a graph. 
Results: Table 20 summarizes the effects of equidepressor doses on 
heart rate. One of the striking features of these data is marked 
variability which was also observed in the control heart rates. Because 
of this variability, it is impossible to show a significant difference 
in these drugs. 
One difference in the effects of these derivatives was noted, 
namely the incidence of arrhythmias. Veratridine, germidine, germerine 
and cevadine produced arrhythmias. In 7 of 21 dogs tested with veratri-
dine, atrioventricular block lasting 9 to 18 seconds was observed. 
Germidine produced asystole lasting 6 to 9 seconds in 5 of 10 dogs 
tested, with evidence of atrioventricular block in two. Administration 
of germerine produced atrioventricular block lasting 9 to 11 seconds 
in 2 of 20 dogs tested. One dog of 20 receiving cevadine had A-V block 
52 
Table 20 
~adycardic Activity of Equidepressor Doses of Veratrum Derivatives in the 
~esthetized Dog 
{1) {2) (3) {4) (5) {6) 
Dose by Control ~eart Rate % Decrease Number Showing 
Veratrum 3 to 5 second Heart Rate Response in Arrhythmias 
Derivative ~travenous Injection Beats/min Beats/min Heart Rate 
mog/kgm Mean & S.D. Mean & S.D. Mean & s.D. No. Tested 
(Range) (Range) (Range) 
Germitrine o.45 135 ± 45 -JA ± 18 9 ± 10 0/20 
(89-211) (o-68) (0-36) 
PNPllf"lF 0.47 129 ± 42 -21 ± 20 17 t 14 0/24 
(76-255) (0-69) (0-49) 
Neogennitrine o.57 143 ± 29 -29 :t 38 18 :t 20 0/20 
(ll2-195) . (o-46) (0-27) 
Germ.erine 0.95 142 :t 34 -29 :t 48 19! 26 2/20 
(91-187) (0-166) (0-90) 
Protoveratrine 1.12 158 ± 32 -21 ± 16 13 :t 9 0/20 
(99-212) (o-68) (0-32) 
Germ.idine 2.08 151 :t 32 -88 :!: 51 56± 28 5/JJJ 
(101-180) (13-157) (25-91) 
Veri1oid" 5 129 ± 31 -36 ! 27 27 ± 21 67&J 
(96-190) (0-72) (0-38) 
Veratridine 10.6 129 ± 29 -56:!: 34 44 ± 27 7/21 
(82-178) (0-110) (0-97) 
Cevadine 30 128 ± 24 -19 :!: 21 14±14 1/20 
(91-180) (0-75) (0-32) 
Acid Extract 208 131 :!: 37 -18 ± 13 14±10 0/20 
(97-190) (0-42) (0-36) 
Veratramine 222 116 :t 39 -20 ± 22 14 ± 12 0/20 
(85-188) (0-73) (0-40) 
- - -- ----
* PNP111 was a mixture of germi trine and neogerm.i trine. 
\J1. 
\...) 
lasting 4 seconds. A normal sinus rhythm was observed during the 
bradycardic response after administration of the other derivatives 
tested. 
The effects of the higher dose are shown in table 21. As with 
the previously described experiments, marked variation was observed. 
Although the dose was increased threefold, the responses obtained 
were wi.. thin the same range. 
In figure 2, the bradycardic responses to the intravenous infusion 
of 10 microgm. of "Veriloid" per kgm. over a 10 minute period expressed 
as beats per minute were plotted against control heart rates. The 
scatter in this graph indicates that there is no virtue in expressing 
the heart rate response as per cent of control values. 
(2) Influence of rate of administration on the cardiac effects of 
11Veriloid11 in the dog. 
Methods: Ten unanesthetized dogs were given various doses of 11Veriloid11 
by rapid intravenous injection (3 to 5 seconds) and by slow intravenous 
infusion (10 minutes). The doses selected were 5, 10, and 20 rnicrogm. 
per kgm. Several days were allowed to lapse between injections in the 
same dog and the order of injection was varied for each dog. 
Results: The results of these experiments are in table 22. Rapid 
intravenous injection (3 to 5 seconds) of 20 microgm. of 11Veriloid" 
per kgm. caused asystole lasting 6 to 20 seconds which was succeeded 
by periods of marked bradycardia during which convulsive movements 
were observed. Ten minute infusions of a similar dose produced only 
sinus bradycardia in 9 of the 10 dogs tested. The remaining dog exhibited 
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(1) 
Veratrum 
Derivative 
PNPlll* 
Gennerine 
Protoveratrine 
Germidine 
,, 
'Veri1oid'' 
Veratridine 
Acid Extract 
- - -
- ----
Table 21 
Bradycardic Activity of Large Doses of Veratrum Derivatives 
in Anesthetized Dogs 
(2) (3) (4) (5) 
Dose by Control Heart Rate 
Number Intravenous Heart Rate Response 
of Injection over a Beats/min Beats/min 
Animals 3 to 5 second period Mean & S.D. Mean & S.D. 
mcg/kgm (Range) (Range) 
5 1.42 121:!: 18 -30 :!: 23 
(100-150) (o-65) 
5 2.85 164 ± 29 -19 ± 38 (118-194) (0-88) 
5 3.45 158 :t 39 -44 ± 28 
(114-187) (0-69) 
5 6.24 121 ± 29 -46 :t 16 
(94-162) (31-63) 
5 15 162 :!: 40 -66 :t 55 
(ll5-227) (0-152) 
5 31.8 118 t 31 -77 :!: 15 
(85-163) (66-102) 
.. 
5 624 92 t 25 -19 :t 25 
(67-125) (o-52) 
- - - --- - - - - --- ------ - ----- - -- · - -~ - - ·- --- -- - - - - - --- - ------
* PNPlll was a mixture of germitrine and neogermitrine. 
{6) 
% Decrease 
in 
Heart Rate 
Mean & S.D. 
(Range) 
25:!: 19 
(o-54) 
ll ± 23 
(0-53) 
27:!: 18 
(0-44) 
37 ± llJ. 
(28-67) 
36 t 24 
(0-66) 
66! 18 
(58-Bo) 
16 ± 22 
(o-46) 
~ 
Table 22 
Bradycardic Action of "Veriloid11 in the Unanesthetized Dog 
(1) (2) (3) (4) (5) (6) 
Control Decrease in % Decrease in 
Number Dose Rate of Heart Rate Heart Rate Heart Rate 
of mcg/kgm Intravenous Beats/min Beats/min Mean & S.D. 
Animals Administration Mean & S.D. Mean & S.D. (Range) 
(Range) (Range) 
10 5 Infused 81.9 :t 20.8 -13.9 ± B.o 16 ± 7.9 
(10 minutes) (6o-132) (o-48) (0-34) 
10 5 Rapid 9t.3 t 12.8 -17.5 ± 15 15.6 ± 18.~. (3-5 seconds) 72-120) (o-68) (o-44) 
10 10 Infused 104 ± 22 -35.2 ± 18.8 32.7! ~ .• 4 
(10 minutes) (76-122) (14-66) (11-48) 
10 10 Rapid 93.1 ± 15.2 -49.8 ± 23 43.1 :t 20.8 
(3-5 seconds) (70-120) (21-72) (23-81) 
10 20 Infused 99.5 ± 21.5 -37 .5* :t 12.4 39.6 ± 15.2 
(10 minutes) (75-130) (18-88) (12-72) 
10 20 Rapid 102 ± 21.5 -78.7* :t 19.7 76.9 ± 25.7 
{3-5 seconds) (64-142) (10-94) (8-84) 
~ -
-- ----- - --- - ---
*These values were significantly different (P = 0.01). 
\.11. 
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atrioventricular nodal rhythm for 15 seconds. Emesis occurred in half 
of these dogs receiving this dose irrespective of the rate of adminis-
tration. 
The dogs which received 5 or 10 microgm. of "Veriloid11 per kgm. 
did not exhibit collapse, convulsive movements, emesis or arrhythmias. 
In summary, in the anesthetized dog 5 or 10 microgm. of 11Veriloid11 
per kgm. produced the same bradycardic response whether given rapidly 
or slowly; however, 20 microgm. per kgm. by infusion gave a smaller 
response than by rapid injection. Slow infusion would appear to be 
the safest method of intravenous administration of 11Veriloid. 11 
(3) Intravenous infusion of veratrum derivatives into unanesthetized 
dogs. 
Methods: These studies were undertaken since they would correspond to 
the conditions under which veratrum would be used clinically. Each 
derivative was tested in 10 animals with the exception of germidine 
which was tested in only 6. 11Veriloid11 (10 microgm. per kgm.) and 
equidepressor doses of the other agents were used. 
Results: The data obtained from these studies are presented in table 23. 
Again, there was a great variability in heart rate response. The re-
sponses produced by the 7 derivatives were not different. 
(4) Cardiac effects of repeated injections of 11Veriloidn and of proto-
veratrine. 
Methods: Seven unanesthetized dogs were given 3 hourly intravenous 
injections (3 to 5 seconds) of 10 microgm. of 11Veriloidn per kgm. 
In a similar fashion, three 2.1 microgm. per kgm. doses of protoveratrine 
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(1) 
Veratrum 
Derivative 
PNPlll* 
Germerine 
Protoveratrine 
Germidine 
11Veri1oid11 
Veratridine 
Acid Extract 
Table 23 
Bradycardic Response to Infusion of Veratrum Derivatives 
in Unanesthetized Dogs 
(2) (3) (4) (5) 
Dose in Control Decrease in 
Number mcg/kgm Heart Rate Heart Rate 
of given r.v. over Beats/min Beats/min 
Animals 10 minutes 1-1ean & S.D. }lean & S.D. 
(Range) (Range) 
10 0.095 102 :!: 27 + ..:25 - 22 
(84-161) (4-81) 
10 0.19 99 :!: 27 -20 :!: 15 
(80-150) (6-51) 
10 0.23 99 ± 22 -31 ± 20 
(85-137) (4-71) 
6 0.417 104:!: 10 -22 t 12 
(85-lll) (7-43) 
10 1.0 104 ± 22 -35 :!: 19 
(76-120) (6-56) 
10 2.12 92:!: 15 -13 ± 11 
(57-109) (0-38) 
10 41.6 93:!: 20 -31:!: 17 
(79-123) (12-65) 
- - -
---- - -~~~--
- - ----- ------ --
* PNP1ll was a mixture of germitrine and neogermitrine. 
{6) 
% Decrease in 
Heart Rate 
Mean & S.D. 
(Range) 
23 t 14 
(4-50) 
18:!: 10 
(11-.34) 
31:!: 16 
(5-52) 
21 ± 12 
(8-43) 
33:!: 14 
(4-48) 
14 ± 12 
(0-39) 
32 ± 13 
(15-52) 
VI. 
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were given at hourly intervals one week later. 
Results: Table 24 contains the results of these experiments. The 
responses to successive doses of these drugs did not differ. Follo~dng 
the second and third injections of protoveratrine, two of the animals 
exhibited atrioventricular nodal rhythm with a few ventricular extra-
systoles lasting from 10 to 15 seconds. 
(b) The role of the vagus nerves in the bradycardic effects of veratrum 
derivatives. 
Methods: The procedures used included cold block of the vagus nerves 
in dogs and section of the vagi in rabbi ts, cats and dogs under various 
anesthetics. Methods were the same as described in the section on the 
vascular action of veratrum derivatives. 
Results: In the dog (table 8) with various anesthetics (table 12) as 
well as in the rabbit (table 10) and cat (table 11) bilateral cervical 
vagotomy abolished the bradycardic response to infusion of 10 microgm. 
of "Veriloid11 per kgm. Temporary interruption of the conductivity of 
the vagus nerves by cold block also prevented the bradycardic action 
of 11Veriloid11 and protoveratrine (table 9). 
(c) Veratrosine antiarrhythmic action. 
Methods (General): The effect of veratrosine on abnormal cardiac rates 
and rhythms produced by 10 different methods was studied in 6o experi-
ments using 36 dogs. Each method was studied in 6 dogs and the type 
and duration of abnormality recorded. When the duration of the 
abnormality was short, the experiment was repeated immediately and 
(1) 
Veratrum 
Derivative 
& 
Dose in 
mcg/kgm 
given over 
a 3 to .5 
second period 
Veriloid 
10 
Protoveratrine 
2.1 
Table 24 
Cardiac Effects of Repeated Administration of 
11Veriloid11 and Protoveratrine to Unanesthetized Dogs 
Injection #1 Injection #2 
(2) (3} {4) (5) (6} (7) (8} 
Control Heart % Decrease Control Heart % Decrease Control 
Heart Rate in Heart Rate in Heart 
Rate Response Heart Rate Rate Response Heart Rate Rate 
Beats/min Beats/min Mean Beats/min Beats/min Mean Beats/min 
Mean Mean & S.D. Mean Mean & S.D. Mean 
& S.D. & S.D. (Range) & S.D. & s.D. (Range) & s.n • . 
(Range) (Range) (Range) (Range} (Range) 
92 t 30 -48 ! 32 51! 23 96 ! 32 -43! 17 46! 14 88 ! 31 
(6o-120) (20-110) (22-76) (50-130) (20-70) (2.5-61) (50-12.5) 
106 ± 29 -42 ! 19 43 ± 22 88! 28 -27 ± 13 32 ± 17 79! 30 
(6.5-16o) (1.5-8.5) (13-74) (.5.5-13.5) (5-4.5) (9-56) (50-140) 
Injection #3 
(9) (10) 
Heart . % Decrease 
Rate in 
Response Heart Rate 
Beats/min Mean 
Mean & s.D. 
& s.n. (Range) 
(Range) 
-39 ± 33 4.5 ! 29 
(.5-9.5) (10-76) 
-20 :!: 23 23 t 17 
(0-70) Co-5o) 
~ 
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veratrosine tested; when the duration of abnormality was long, vera-
trosine was tested in a similar experiment several da~s later. 
Methods and Results: The first five methods were grouped together 
because each of the agents utilized produced a supraventricular 
tachycardia. Also, in these groups, the administration of veratrosine 
preceded the intravenous injection of the agent producing the tachy-
cardia. Thus, the experimental design was such that the protective 
effect of veratrosine against agents producing tachycardia was studied. 
The results are shown in table 25. 
The administration of ephedrine during cyclopropane anesthesia 
produced supraventricular tachycardia (276 ~ 20 beats per minute) 
which lasted for at least one hour. The injection of ephedrine, 15 
minutes after veratrosine had been administered, produced only a 
slight increase in heart rate (from 102 ! 5 to 147 ! 25 beats per 
minute). · These rates were significantly slower (P = o.ol) than those 
observed during the control periods. The effect of veratrosine lasted 
at least 75 minutes because the heart rate one hour after the injection 
of ephedrine was 137 ~ 22 beats per minute, whereas in the control experi-
ments it was 250 ! 22 beats per minute. 
In unanesthetized dogs, the intravenous injection of 10 mgm. of 
hydralazine per kgm. produced a marked supraventricular tachycardia 
(212 ! 30 beats per minute) of at least one hour duration. The maximum 
rate observed after the administration of hydralazine (139 ! 6 beats 
per minute) to the animals which 5 minutes previously received veratrosine 
(400 microgm. per kgm.) was significantly lower (P = 0.01). Again, re-
sults indicate that the effect of veratrosine lasted for at least 65 
62 
Table 25 
The Effect of Veratrosine on Supraventricular Tachycardia 
(1) (2) {3) {4) (5) (6) (7) (8) (9) 
Control Maximum H.R. One 
Tachycardic Rqute Dose Heart H.R. Hour Dose of Route H.R. After 
Agent or of Rate After After Veratrosine of Veratrosine 
(T.A.) T.A. T.A. (H.R.) T.A. T.A. mcg/kgm Administ. Beats/min 
& Number of Beats/min Beats/min Beats/min given over Veratrosine Mean & s.n. 
Dogs Mean Mean Mean a 1 min. (Range) 
& S.D. & s.n. & S.D. period 
(Range) (Range) (Range) 
Ephedrine 
during 
139 ! 42 276 ! 20 cyclopropane r.v. 2 mcg/kgm 250 :!: 22 400 r.v. 102 ~ 5 
anesthesia (80-190) (245-300) (220-285) (9.5-110) 
6 
Hydralazine r.v. 10 mgm/kgm 98:!: 14 212 :!: .30 189 :!: 30 400 r.v. 93 t 25 
6 (80-120) (170-26o) (16o-215) (65-140) 
Isopropyl-
94 ~ 23 264 :!: 35 arterenol r.v. 5 mcg/kgm 
--
400 r.v. 72 :!: 23 
6 (6o-120) (210-305) (6o-115) 
Isopropyl-
89 :!: 35 244 ! 29 arterenol r.v. 5 mcg/kgm 
--
12000 Oral 15 :!: 24 
6 (45-145) (215-295) (40-110) 
Dibenamine 
& r.v. 20 mgm/kgm 93 :!: 21 247 :!: 27 
--
400 r.v. 93 t 8 
Epinephrine 10 mcg/kgm (6o-n5) (190-270) (80-105) 
6 
*These values were different from those in column 5 (P = o.Ol). 
(10) 
Max. H.R. 
After T.A. 
& 
Veratrosine 
Beats/min 
Mean & S.D. 
(Range) 
147*:!: 25 
(130-16o) 
139* :!: 6 
(120-170) 
147*:!: 22 
(130-170) 
164* :!: 16 
(130-190) 
122* :!: 8 
(105-130) 
{11) 
H.R. One 
Hour After 
T.A. & 
Veratrosine 
Beats/min 
Mean & S.D. 
(Range) 
137 :!: 27 
(110-180) 
132 :!: 10 
(120-145) 
--
--
--
{)'\ 
\.U 
minutes. 
A supraventricular tachycardia (264 ~ 35 beats per minute) of 
short duration was produced by the intravenous injection of 5 microgm. 
of isopropylarterenol per kgm. into unanesthetized dogs. Administra-
tion of 400 microgm. of veratrosine per kgm. was followed by injection 
ot isopropylarterenol at intervals of 15 minutes for four doses. Vera-
trosine gave significant protection (P = 0.01) whether given by the 
intravenous (maximum heart rate of 147 ! 22 beats per minute) or by the 
oral route (maximum heart rate of 164 t 16 beats per minute). It 
should be noted, however, that the oral dose (12 mgm. per kgm.) was 
30 times the intravenous dose (400 microgm. per kgm.). 
Supraventricular tachycardia (247 ! 27 beats per minute) of short 
duration was also produced by the intravenous administration of 10 
microgm. of epinephrine per kgm. to unanesthetized dogs which had pre-
viously received 20 mgm. of dibenamine per kgm. As with the other 
methods of producing supraventricular tachycardia, here too, veratrosine 
exhibited a significant (P = 0.01) protective action of at least one 
hour duration (maximum rat e of 122 ~ 8 beats per minute). 
Table 26 contains the results of the experiments in which atro-
pine and those in which phentolamine were used as the agents to produce 
cardiac abnormalities. Atropine (l mgm. per kgm.) produced a supra-
ventricular tachycardia (253 ! 22 beats per minute) which lasted for at 
least one hour while phentolamine (1 mgm. per kgm.) produced a tachy-
cardia of slower rate (178 ! 31 beats per minute) and of shorter duration. 
The tachycardia observed after phentolamine administration subsided 
(1) (2) 
Tachycardic Dose in 
Agent mgm/kgm 
(T.A.) & Route 
& of T.A. 
Number of 
Dogs 
Atropine 1.0 
6 r.v. 
Phentolamine 1.0 
6 r.v. 
Table 26 
The Effect of Veratrosine on Atropine or Phentolamine-
Induced Supraventricular Tachycardia 
(3) (4) (5) {6) (7) 
Maximum H.R. One Dose in 
Control Heart Rate Hour After meg/kgm Control H.R. 
Heart Rate (H.R.) T.A • . & Route of Beats/min 
Beats/min After T.A. Beats/min Veratrosine Mean & S.D. 
Mean & S.D. Mean & S.D. Mean & S.D. given over (Range) 
(Range) (Range) (Range) a 
1 min period 
95:!: 11 253 :!: 22 219 :!: 39 400 93 t 15 
(80-110) (230-280) (175-280) r.v. (70-115) 
93! 10 178 :!: 31 115 :!: 31 400 
--(80-100) (120-210) (85-170) r.v. 
*These results were different from those in column 5 (P • 0.01). 
(8} 
Minimum 
H.R. 
After T.A. & 
Veratrosine 
Beats/min 
Mean & S.D. 
(Range) 
100 :!: 19 
(80-135) 
83:!: 15 
(00-100) 
(9} 
H.R. One 
Hour After 
T.A. & 
Veratrosine 
Beats/min 
Mean & S.D. 
(Range) 
123* t 21 
(100-155) 
98 ± 22 
(65-130) 
~ 
\J1. 
gradually and at one hour the heart rate (115 t 31 beats per minute) 
was within the range of that observed during the control period, 
(93 ± 10 beats per minute). The administration of veratrosine after 
atropine-induced tachycardia had been produced, resulted in a return 
of the heart rate to control levels (100 t 19 beats per minute) in 15 
(! B) minutes. The heart rate then remained at this level for at least 
one hour (123 t 21 beats per minute). The central nervous system stimu-
lation caused by atropine was not obviously affected by veratrosine 
administration. The intravenous injection of veratrosine immediately 
after the administration of phentolamine prevented the development of 
any significant (P = 0.01) increase in heart rate (93 + 10 to 98 + 22 
beats per minute). 
The results of the experiments in which the effects of veratrosine 
on tachycardia produced by ephedrine in dogs anesthetized with cyclopro-
pane are presented in table 27. The administration of veratrosine after 
supraventricular tachycardia (279 ! 17 beats per minute) had been pro-
duced, resulted in a diminution of the heart rate to values (126 ! 10 
beats per minute) less than that observed during the control period 
(157 ! 34 beats per minute) for at least one hour. 
Table 28 summarizes the experiments in which the effects of vera-
trosine on ventricular arrhythmias were studied. The rate and the 
duration of the ventricular arrhythmia were the criteria used as the 
indication of the severity of the arrhythmia produced by 10 microgm. 
epinephrine per kgm. infused over 5o seconds into dogs anesthetized with 
cyclopropane. The intravenous administration of 400 microgm. of vera-
trosine per kgm. did not alter the severity of the epinephrine-cyclopropane 
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',I'able 27 
E£fect o£ Veratrosine on Cardiac Abnormalities Produced 
· by Ephedrine During Cyclopropane Anesthesia 
~---
(1) (2) (3) (4) {5) (6) (7) 
Control Maximum Dose in Minimum 
Number Dose in Heart Rate H.R. After mcg/kgm H.R. After Time of 
of Dogs mgm/kgm (H.R.) Ephedrine & Route o£ Veratrosine Min. H.R. 
& Route Beats/min Beats/min Veratrosine Beats/min in Minutes 
of Mean & S.D. Mean & S.D. given over a :Hean & S.D. Mean & S.D. 
Ephedrine (Range} (Range) 1 min period (Range} (Range) 
6 2 1.54 :!: 37 279 :!: 17 400 126* ± 10 30:!: 8 
r.v. (100-200) (26o-300) r.v. (110-140) (20-42) 
- - - --- - - - -- - --- -~-- --- - ------- ---
* These results were different £rom those in column 4 (P = O.Ol). 
(B) 
Heart Rate 
One Hour After 
Ephedrine& 
Veratrosine 
Mean & s.n. 
(Range) 
127 :!: 10 
(110-140) 
. 
0"-
-.J 
Table 28 
The Effect of Veratrosine on Ventricular Arrhythmias Produced 
qy Epinephrine During Cyclopropane Anesthesia 
(1) (2) (3) (4) (5) (6) (7) (8) 
Maximum H.R. Duration of Dose in Max. H.R. 
Number Dose in Control After Ventricular mcg/kgm H.R. After After 
of Dogs mcg/kgm Heart Rate Epinephrine Beats in & Route of Veratrosine Epinephrine 
& Route Beats/min Beats/min Seconds Veratrosine Beats/min & Veratrosine 
Of :r-Iean & s.n. Mean & S.D. Mean & S.D. given over a Mean & S.D. Beats/min 
Epinephrine (Range) (Range) (Range) 1 min period (Range) Mean & S.D. 
(Range) 
6 10 178 :!: 19 .305* :!: 10 55** -! 8 400 91 t 17 .305*' :!: 10 I.v.- (155-200) (300-320} (45-63) I.v. (6o-105) (.300-320) 
-- . - - - ~ - - - - - ~ - -- - ~ - --- ---- ----- -
* These values were not diff erent (P • 0.5). 
** These values were not different (P = 0.5). 
(9) 
Duration of 
Ventricular 
Beats in 
Seconds 
Mean & S.D. 
(Range) 
6.(* t 10 
(54-72) 
~ 
CX> 
induced ventricular arrhythmias as evidenced by the fact that the rate 
(305 ! 10 beats per minute) and the duration (65 ! 10 seconds) of the 
multifocal ventricular tachycardia were identical to those observed in 
the untreated dogs (305 :t 10 beats per minute for 55:!: 8 seconds). 
Rapid intravenous injection of 3 microgm. of epinephrine per kgm. into 
vagotomized dogs anesthetized with pentobarbital produced a marked 
pressor response (212 :!: 40 mm. Hg.) and tachycardia (232 ! 20 beats per 
minute) (table 29). Complete protection against this tachycardic re-
sponse was given by the administration of 400 microgm. of veratrosine 
per kgm. (maximum rate of 117! 36 beats per minute), but the pressor 
response (194! 28 mm. Hg.) was not significantly different (P = o.5). 
The injection of epinephrine one hour after veratrosine administration 
did not produce any appreciable increase in heart rate (maximum rate of 
130 ! 23 beats per minute) indicating that the veratrosine effect lasted 
at least this long. 
Irregular regurgitation was the only side action observed in the 
unanesthetized animals receiving veratrosine. 
From the results of these experiments, the following conclusions 
may be drawn.: (1) veratrosine protects against a variety of drug-induced 
supraventricular tachycardias. (2) 400 microgm. of veratrosine per kgm. 
does not prevent ventricular arrhythmias induced b.Y epinephrine in cyclo-
propane anesthetized dogs. (3) experiments in vagotomized dogs suggest 
that the vagus nerve is not important in the protection given by vera-
trosine against supraventricular tachycardias. (4) the duration of the 
protective action of veratrosine is at least one hour, and (5) veratrosine 
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(1) (2) (3) 
Dose in Control 
Number mcg/kgm Heart 
of & Route Rate 
Dogs of (H.R.) 
Epinephrine Beats/min 
Mean 
& s.D. 
(Range) 
6 3 175 :t 30 
r.v. (130-200) 
Table 29 
The Effect of Veratrosine on Epinephrine-Induced 
Cardiac Abnormalities 
(4) (5) (6) (7) {8) 
Control Maximum Ilose in 
Iv.Iaximum Blood Bl. Press. mcg/kgm H.R. After 
H.R. After Pressure After & Route Veratrosine 
Epinephrine mmHg l!:pinephrine of Beats/min 
Beats/min Mean rnm Hg Veratrosine Mean & S.D. 
Mean & S.D. & S.D. )1ean & s.n. given over (Range) 
(Range) (Range) (Range) a 1 min 
period 
232 ! 20 139!28 212 ! 40 4oo 100 t 37 
(205-265) (105-154) (170-280) r.v. (80-150) 
One Hour After 94 t 26 
Veratrosine (6o-120) 
Administration 
~These values were different from those in column 4 (P = 0.01). 
**These values were not different from those in column 6 (P = 0.5). 
(9) {10) 
Max. H.R. Bl. Press. 
After After 
Epinephrine Epinephrine 
& & 
Veratrosine Veratrosine 
Beats/min mmHg 
Mean & S.D. Mean & S.D. 
(Range) (Range) 
117* t 36 123 t 16 
(70-165) (96-144) 
130* ± 23 119 :t 22 
(100-180) (90-144) 
(11) 
Max. Bl. 
Press. After 
Epinephrine 
& 
Veratrosine 
rnm Hg 
Mean & S.D. 
(Range) 
194-l''* ± 28 
(158-240) 
190** :!: 29 
(162-220) 
--:J 
0 
does not affect the pressor action of epinephrine although it completely 
blocks the positive chronotropic action of this drug. 
Discussion: The cardiovascular actions of veratrum derivatives have 
been ascribed to a direct effect on the blood. vessels, to reflexes 
originating from the areas in the lungs and heart supplied by the vagus 
nerves or the carotid sinus, and to an effect on the central nervous 
system. Probably all of these areas are aff ected to some extent qy 
veratrum derivatives under specific experimental conditions; however, 
it is not clear which contributes most to the depressor response. It 
would be desirable to know the mechanism involved in the veratrum-
induced depressor response in the intact animal. 
The present observations indicate that veratrum derivatives can 
produce a depressor response by two means: (a) by a direct action on the 
central nervous system and (b) by a reflex card.iodecelerator effect 
mediated by way of the vagus nerves. That the bradycardia produced by 
the 11von Bezold" reflex, which depends on the afferent and efferent vagal 
f i bers from the region of the heart and lungs is the major factor in the 
depr essor ef fect of veratrum, therefore, seems to be questionable. 
Von Bezold and Hirt in 1867 f irst described an action of veratrine 
(a mixture of veratridine and cevadine) depending mainl y on the ar£erent 
vagal fibers. The number of experiments performed was not stated but 
may be assumed to be at least three. They reported that cutting the vagus 
nerves abolished the depressor response, while sectioning of the depressor 
nerves had no effect. These authors concluded that the integrity of the 
vagus nerves in the rabbit was essential for the production of the 
71 
veratrum-induced depressor response. They hypothesized that this effect 
might be due to a change in the sensitivity of the pressoreceptor end-
ings to the usual stimuli. Our experiments suggest that sectioning of 
the vagus nerves in the rabbit, alone or combined with atropinization, 
did not influence the fall of blood pressure seen after administration 
of 11Veriloid. 11 This discrepancy may be due to the use of a diff erent 
veratrum derivative. "Veriloid11 is a mixture of alkaloids from Veratrum 
viride which probably includes some veratridine and cevadine; and there 
is no evidence that "Veriloid11 differs greatly from any of the other 
veratr~~ derivatives. The number of experiments performed might explain 
the discrepancy since the variability observed in our animals either 
intact or vagotomized (table 10) indicates the possibility of drawing 
incorrect conclusions from too few anLmals. It seems clear that the 
integrity of the vagus nerves is not essential for the production of the 
11Veriloid11-induced depressor response in the rabbit. 
Cramer (1915) experimenting on cats anesthetized with chloroform 
reported results which supported those of von Bezold. He observed that 
the injection of an extract of Veratrum viride produced a depressor 
response with but little bradycardia; he also observed that a second in-
jection of Veratrum viride in the cat failed to produce a depressor 
"' response. He concluded that veratrum first stimulated the mechanism 
whereby it acts and then paralyzed it. Administration of atropine 
abolished the bradycardia but did not influence the fall in blood pressure. 
Bilateral cervical vagotomy, hoirever, was said to abolish this effect. 
His conclusions were that "Veratrum viride produces its effect reflexly 
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through stimulation of the afferent vagus fibers." Jarisch and Richter 
(1939) using veratrine, and Jones (1953) using veratridine, also noted 
the phenomenon of tachyphylaxis produced by repeated intravenous in-
jections in cats. In our experiments using "Veriloid, 11 tachyphylaxis 
on repeated injections into cats was also observed (table 11). This 
phenomenon was especially marked in vagotomized animals. Jarisch and 
Richter (1939) observed inconstant depressor responses after the first 
injection of veratridine into cats whose vagus nerves were interrupted 
by cold block. Further injection of veratridine into these animals 
failed to produce a depressor response. Although a fall in blood pressure 
was observed in vagotomized cats after the first injection and tachyphy-
laxis was recognized, they concluded that the depressor response was de-
pendent upon impulses traveling in the vagus nerves. Jarisch and Richter 
(1939), Dawes (1951) and Jones (1953) observed that cold block of the 
vagus nerves during the depressor response of veratrum resulted in a rise 
in blood pressure; but other factors such as stimulation of the vagal 
fibers by the process of cooling might account for their results. Borison 
and Fairbanks (1952) reported that bilateral cervical vagotomy in the cat 
did not alter the depr essor response to "Veriloid." They reported, how-
ever, that sectioning of the vagus nerves above the nodose ganglia 
abolished the depressor response. In a recent publication, Borison 
(1953) was unable to confirm this observation but reported that denerva-
tion of the bifurcation of the common carotids combined with bilateral 
removal of the nodose ganglia was necessary to abolish the depressor re-
sponse. He evidently did not recognize the phenomenon of tachyphylaxis 
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since his results are based on animals which received multiple doses of 
"Veriloid" at intervals of 5 to 10 minutes. To avoid tachyphylaxis, 
our experiments were performed in cats which had not received any 
veratrum prior to bilateral cervical vagotomy. Under these conditions 
vagotomy did not alter the depressor response. We were also able to 
demonstrate that the region in which the vagus nerves were sectioned 
did not quantitatively alter the response. The discrepancies between 
our results and those of previous investigators are best explained by 
their failure to compensate for tachyphylaxis and for the effect of 
SliTgery on the cardiovascular responses of the cat. It seems justifiable 
to conclude that the integrity of the vagus nerves or the nerves supply-
ing the carotid bifurcations is not essential to the "Veriloid"-induced 
depressor response in the cat. 
MacNider (1925) reported that the injection of a tincture of 
Veratrum viride into dogs anesthetized with morphine sulfate and ether 
resulted in a "rapid decrease in the rate of the heart and a fall in the 
systolic blood pressure." He observed that bilateral cervical vagotomy 
or the administration of atropine sulfate did not abolish the depressor 
response and concluded that "reflex slowing of the heart through the 
vagus is responsible for a considerable amount of the blood pressure 
drop." Willson and Smith (1943) observed that "in 12 dogs to which 
11Veratrone11 was given before vagotomy, the first dose of the drug after 
section of the vagus nerves was followed by a fall in blood pressure and 
an increase in leg volume in all instances although of a lesser degree 
than that which occurred with intact vagus." These authors concluded 
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that "the fall in blood pressure following the injection of Veratrum 
viride in anesthetized dogs is primarily a result of vagal inhibition 
of carciac action which masks the fall in blood pressure due to peripheral 
vasodilatation." Moe, Basset and Krayer (1944) presented evidence which 
would make it appear unlikely that a direct effect of veratrmn. on the 
blood vessels is the cause of the depressor response. They observed that 
injection of a veratrum derivative into the isolated perfused hind leg 
of the dog did not result in an increase in leg volume. These authors 
also reported that vagotomy decreased the depressor response but rarely 
abolished it. In three of the ten experiments performed, "the relative 
vasodilator effect in the femoral arteries was as marked as before vago-
tomy." Dawes, Mott and Widdecomb (1951) reported similar results for 
their experiments in which "Veriloid11 was used. Stutzman, Simon and 
Maison (1951) demonstrated that bilateral cervical vagotomy in the pento-
barbital anesthetized dog did not quantitatively alter the depressor 
response to the intravenous infusion of any of six different veratrum 
derivatives. Gruhzit, Freyberger and Moe (1953) reported that "the de-
pressor action of "Veriloid" in dogs was abolished by section of the vagi 
and carotid sinus nerves but not by either procedure alone." Our experi-
ments with 11Veriloid 11 agree with those of Stutzman, Simon and IYiaison 
(1951) and those of Gruhzit, Freyberger and Moe (1953) in that bilateral 
cervical vagotomy did not alter the depressor response to 11Veriloid. 11 
These results differ from those of Moe, Bassett and Krayer (1944) and 
Dawes (1951) in that these workers observed a decrease in the depressor 
response after vagotomy; their experimental preparations, however, differ 
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radically from the intact animal since injection of veratridine directlY 
into the right auricle may stimulate receptors in this area which are 
not involved in the depressor response after intravenous injection into 
intact dogs. This point must be considered especially since Jarisch 
and Zotterman (1948) have shown that any irritant injected directly 
into the coronary arteries will stimulate 11 chemoreceptors 11 and produce 
a bradycardic and depressor response. The discrepancy between our 
results and those of Dawes (1951) cannot be readily explained. Some 
workers (Dawes 1951, Hoobler 1953) are of the opinion that the species 
of animal used and the type of anesthetic administered might explain 
the divergent results in the literature. The results of the present 
series of experiments indicate, however, that neither species (tables 
8, 10, ll) nor anesthesia (table 12) influenced the magnitude of 11Veriloid11 -
induced depressor responses in intact or in vagotomized animals. 
Evidently, other areas than those innervated by the vagus nerves con-
tribute to the depressor response after injection of veratrum derivatives 
into vagotomized animals. A few investigators (Heymans and Heymans 1926, 
Dawes 1947, Aviado and Pontius 1949, Gruhzit et al 1953) have presented 
evidence to show that the carotid sinus area may function to some extent 
in the depressor response. These experiments consisted mainly of injecting 
a veratrum derivative into the isolated perfused common carotid bifurca-
tion. A marked bradycardia and depressor response was observed following 
this procedure. The marked degree of bradycardia raises . the question if 
the depressor response observed was not due entirely to the slowing of the 
heart rate. It is also difficult to compare these results with those 
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observed in the intact animal after intravenous injection since the 
concentration of veratrum i n the blood is probably much lower i n t he 
l at ter. Gruhzit, Freyberger and Moe (1953) r eported that section of 
t he carotid sinus nerves combined with bilateral cervical vagot omy 
abolished the depr essor response to 11Ver iloid. 11 We have been unable to 
confirm these results. The length of time that the blood pressure of 
the animal was followed may be involved in this discrepancy since we 
observed that the depressor response in these animals occurred at a 
later time t han i n intact animals. Richardson, Farrar and Halker (1951) 
have described an assay based on veratr~~-induced depression of the 
carotid sinus pressor reflex in vagotomized dogs. They concluded that 
this action was independent of the veratrum depressor effect; however, 
thi s concept is not in agreement with the results reported in t his 
t hesi s, which demonstrat e that verat rum derivatives do not possess any 
adrenergic, sympathetic or ganglionic blocking action. This discrepancy 
can perhaps best be explained by ·t.he fact that Prochnik, Haison and 
Stutzman (1950) demonst rated that the carotid sinus pressor response was 
proportional to the existing mean arterial pressure. 
Several previous investigators have noted a centrally mediated de-
pressor effect of veratrum derivatives, but t heir interpretation was 
that this action was unimportant. Richter and Thoma (1939) compared 
the responses to veratrine administered through the jugular vein with 
the responses af ter injection into the vertebral artery in normal cats. 
They concluded that the central action required higher dosage, but the 
results can also be explained on the basis of tachyphylaxis since the 
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inj e ctions i nto the ver-\:,ebral artery Here made after those into the 
jugular vein . DavJes (1947) i n j ected small closes into the cor onary ci r -
culat j_on and concluded that both cardiodecel erator and depressor actions 
Here princi~)ally ref lex in nature t hauc;h he recoenized t he central coq-
ponen·t:. . Da-v;es makes no mention of control solvent i n j ections into t he 
r:or onary arter ies. The absen ce o.f cont r ol i n j ections brings i nto question 
C.~e physiol of,i cal :i_mport<mce of t hese r e sponses as specific effects of 
veratr u.rn. s i nce J aris ch and L:otteTman (1948) demons t rated that irritative 
substa.nces i n t he coronc.r3,. a!·teries r ec.dily elicit bradycardia and a 
de~)ressor response . Tayl or and Page (1951) have publi shed e:zperiments 
on "Tferiloid " supporti11;5 the central depr essor action proposed by 
"·'·utzman c -; ·man "'n -l 'lial· son ( 1 9~1 ' ;_, V . _ . __ ' 0--- - CU 1- ·- 1... - - ..-'- j • 
The meaning oi.' t he term rrvon Bezold reflex" has been vo.rio' s l y 
i n terpreted . All at,;ree th.?.t it is avagc-~l r ef l ex vJhit:h pro:h ces brady -
cardia 1>Ji t h a f ferents orie;i nating i n the left ventricle . The question o_ 
-..rhether the sam.e afferent i mpul ses i:'rom the l eft ven·t:.ri cl e can evoke v.?_so -
dilat ation by reflex means is not clec;.r. C•f ·iJhe prGsent. serie s oi' cros s 
drculation experi!11ents (tabl es 15, 16, 17, 18) , onl;r ·iJhose r1 one ~·Ji th 
c. i,ropine ha're bea.~j_ng on t his c.  uesti on since vagotomy ctcts botl1 a ''.:::'erents 
and e f.terents. ;,fuen atro~ .. :Lne is u">ed, the br adycardia i s blocked, but 
s i nce the afferents ere not blocked a reflex v.?.sodilata t5.on :e possi bl3 . 
Under these condi-J:,ions , 11Veriloid" or protoveratr-ine di d not, produce a 
dep:ressor response lfJhen c onf:Lned to t he body of the n3ci p:Lmt. . I-'::, 1nti.ld 
al:..pear ·iJ _a t t hg !tyrn Lezold refl exn pro UC'es only brc.dyc2.!.~dia e."0.d t hat 
the vasodilate.tion i s causer:~ by an acti on of "Veriloid, !I p ro·C.overat rine , 
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veratridine or veratramine on the central nervous system. 
The results of the present series of cross circulation experiments 
with the nerves to the common carotid bifurcation intact or cut confirm 
Aviado's (1949) conclusions that the carotid bifurcations are not 
important to vasodilatation. They confirm Krayer (1949) and Moe (1944) 
in shorrlng that veratramine and veratridine, respectively, were capable 
of slowing the denervated or atropinized heart. On the contrary, 
Heymans and de Vleeschhouwer (1950) present evidence that veratridine 
is incapable of such direct action on the sino-atrial node and produces 
a central nervous system type of bradycardia. No evidence of the type 
of response was obtained in our experiments however. In attempting to 
understand the discrepancy between our results and those of Heymans, 
one must consider the differences in doses. The doses we used were equi-
depressor doses which produced approximately 30 per cent fall in blood 
pressure. By contrast, Heymans employed doses of veratridine which 
were large and the absence of control solvent injections may be signifi-
cant since strongly acid aqueous solutions or large amounts of organic 
solvents might be required to dissolve such doses of veratridine. 
Heymans and de Vleeschhouwer (1951) stated that veratridine was 
the most effective of the veratrum derivatives in eliciting bradycardia, 
although no experimental data were advanced. Our experiments indicate 
that veratridine is a potent bradycardic agent but that it may be 
surpassed in potency by germidine. One is hesitant to make a definite 
statement about these agents because of the great variability of the 
bradycardic responses. A feature of these results is that several of 
the derivatives are capable of producing arrhythmias within the dosage 
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range in which the majority produce only bradycardia. Veratridine, 
germidine, germerine, and cevadine exhibit this property after rapid 
intravenous injection. 
Perhaps of more interest is the bradycardic activity of proto-
veratrine. The latency for protoveratrine bradycardia, first reported 
by Krayer (1943) has been shown to be independent of the rate of adminis-
tration. That is, slow or fast injections produced a similar gradual 
onset of bradycardia. The effect of protoveratrine on the conductive 
tissue of the heart is a notable side action. Although Krayer (1944) 
has reported tachyphylaxis to protoveratrine, our experiments in the 
dog indicate that if sufficient time is allowed for the blood pressure 
to return to control values, tachyphylaxis is not evident. 
The results of these experiments indicate a definite difference 
between 11Veriloid11 and protoveratrine. The germine esters present in 
11Veriloid11 produce rapidly developing bradycardia, whereas protoveratrine 
produces bradycardia •dth a longer latent period. 
Wedd (1926) first described a beneficial effect of an alcoholic 
solution of Veratrum viride on cardiac arrhythmias consisting of a 
quinidine-like effect on auricular muscle. The decrease in heart rate 
he obtained was of small magnitude, and he concluded that Veratrum 
viride was "handicapped by uncertainty and irregularity of action11 in 
cases of auricular arrhytbmias. Other cases of auricular tachycardia 
(Collins 1918, Case Records of the MGH 1939, Shaw 1948) in which a 
tincture of Veratrum viride was used indicated a mildly beneficial action. 
The recent isolation of pure alkaloids of veratrum has stimulated the 
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investigation of this action. Krayer (1949, 195o) reported that vera-
tramine and veratrosine possessed the property of antagonizing the 
cardioacceleration produced by the infusion of epinephrine into the 
heart-lung preparation of the dog. Of the several agents tested, 
Krayer concluded that veratrosine was the most potent. He also ob-
served that veratrosine did not produce convulsions as did veratra-
mine. Veratrosine in doses up to 30 microgm. per kgm. per minute was 
reported neither to antagonize the tachycardia produced by the infusion 
of epinephrine nor to interfere with the vasopressor effect of epine-
phrine in the dog. 
The effect of a tincture of Veratrum viride on phentolamine-induced 
tachycardia was studied in the intact dog by Yonkman, Plummer and Reitze 
(19)2). It was concluded that partial to complete protection was afforded 
by 25o microgm. of veratramine per kgm. or by 1 to 2 ml. of a 1:100 
dilution of a tincture of Veratrum viride although the data offered were 
equivocal. 
The restllts of our experiments confirm previous reports of an effect 
of veratrum derivatives on auricular tachycardia. It has been demon-
strated that veratrosine will protect against supraventricular tachycardia 
and will revert this type of abnormality to a normal sinus rate. It has 
been shown that veratrosine did not protect against ventricular arrhyth-
mias. 
The protective action of veratrosine against supraventricular tachy-
cardia, although only occasionally complete, ~~s in all cases significant. 
The only side action noted was regurgitation in contrast to convulsions 
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which are frequently seen after veratramine. 
A comparison of the properties of veratrosine vdth those of 
other veratrum derivatives demonstrates several dissimilarities. At 
the dose used in these experLments, verat rosine did not produce any 
significant depressor response or bradycardia, which are the main 
acti ons of other veratrum derivatives. A close correlation of emetic 
'~th depressor acti vity has been demonstrated for other veratrum 
derivatives (Swiss 1952) in contrast to veratrosine which produced emesis 
at a dose which did not cause a fall in blood pressure. It has also 
been shown that the oral emetic and depr essor doses are equal to the 
intravenous emetic and depressor doses respectively for many veratrum 
derivatives. It was observed on the contrary, that the oral dose of 
veratrosine was 30 times the intravenous dose for comparable cardiac 
action. 
The mechanism of action of veratrosine on the heart has not been 
elucidated, but some theories have been suggested. Wedd (1926) stated 
that the tinctur e of Veratrum viride which he used had a quinidine-like 
action. Krayer (1950) suggested a "competitive nature of the antagonism 
to epinephrine and norepinephrine." The present series of experiments 
in the vagotomized dog leads one to postulate a direct action on the 
heart, perhaps similar to that of quinidine. 
Conclusions: 
(l) "Veriloid11 does not possess any sympathetic, adrenergic or ganglionic 
blocking activity. 
(2) The vagus nerves are not essential for the production of the depressor 
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response after administration of "Veriloid" to rabbits, cats or dogs. 
The interruption of these nerves by either section or by cold block 
does not alter the response to "Veriloid" or protoveratrine. 
(3) The type of anesthetic used does not influence the magnitude of 
the 11Veriloid11 depressor response in the intact or vagotomized dog. 
(4) The integrity of the vagi and the nerves of the common carotid 
bifurcations are not essential to the fall in blood pressure produced 
by 11Veriloid11 in the dog. 
(.5} 11Veriloid, 11 protoveratrine, veratridine and veratramine act upon 
the central nervous system to lolrer blood pressure. 
(6) Toxic doses of "Veriloid11 have a pressor effect which is due to 
release of endogenous epinephrine. 
(7) Veratridine, germidine, germerine and cevadine produce cardiac 
arrhythmias; equidepressor doses of other veratrum derivatives produce 
only bradycardia and a fall in blood pressure. 
(8) Cardiac abnormalities produced by a given dose of "Veriloid11 are 
reduced by increasing the duration of intravenous administration. 
(9) Veratrosine is a potent agent for the prevention and treatment of 
experimentally produced supraventr icular tachycardia. 
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Abstract 
Veratrum derivatives are best known for their action on the cardio-
vascular system, namely, a fall in blood pressure and bradycardia. 
Although these agents have been known from the time of Hippocrates, the 
exact site or sites of action have not been adequately elucidated. A 
review of the literature indicates that the cardiovascular actions of 
veratrum have been ascribed to a direct effect on the blood vessels, to 
reflexes originating from the areas in the heart and lungs supplied qy 
the vagus nerves or the carotid sinus and to an effect on the central 
nervous system. Probably all of these areas are affected to some extent 
by veratrum derivatives under specific experimental conditions; however, 
it is not clear which contribute most to this depressor response. The 
role of the vagus nerves in the depressor action is one of the chief 
sources of controversy. Most of the previous investigations have empha-
sized the "von Bezold" reflex as the main mechanism of action; it has been 
described as a vagal reflex with afferents originating in the left ventricle. 
All agree that this reflex produces bradycardia, but the question of 
whether the same afferent impulses can evoke vasodilatation by reflex 
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means is not clear. An adequate explanation of the role of the central 
nervous system in the depressor effect has not yet been reported. It would 
be desirable to know the mechanism involved in the veratrum-induced depressor 
response in the intact animal, therefore an investigation of the cardio-
vascular effects of veratrum derivatives was undertaken. Comparison of 
past investigations is rendered difficult because of the variety of tech-
niques employed. In the present experiments, equidepressor doses as 
determined by the dog assay method were used. 
Although it has been shown that during the depressor effect of 
veratrum, vasoconstrictor agents or stimuli produced a qualitative~ 
normal response, no quantitative data have been previously presented. 
Experiments were undertaken to determine whether or not veratrum possessed 
any adrenergic, sympatholytic or ganglionic blocking activity. The de-
pressor effect of 11Veriloid11 did not alter the pressor response to epine-
phrine, 1-norepinephrine or splanchnic nerve stimulation; therefore, it 
probably does not possess adrenolytic or sympatholytic activity. 11Veriloid11 
did not alter the pressor response to bilateral carotid occlusion, hence 
it probably does not possess ganglionic blocking activity. 
Studies were undertaken in an attempt to clarify the role of the 
vagus nerves in the depressor action of veratrum. These included cold 
block of the vagus nerves in dogs and section of the vagi in rabbits, cats 
and dogs under various anesthetics. The depressor responses to intravenous 
administration of 11Veril9id11 in intact or vagotomized pentobarbital anes-
thetized dogs were not different. The bradycardia, however, was abolished 
by vagotomy. These experiments demonstrated that the fall in blood pressure 
after 11Veriloid11 was not dependent upon the integrity of the vagus nerves. 
The fall in blood pressure follo'tdng ac4ninistration of 11Veriloid11 or proto-
veratrine during cold block of the vagus nerves was not significantly 
different from the response observed during the control periods before and 
after cold-block. The bradycardic response to "Veriloid11 or protoveratrine 
was abolished during cold block of the vagi. A definite difference 
between 11Veriloid11 and protoveratrine was observed. The germine esters 
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present in "Veriloid" produced rapidly developing bradycardia, whereas 
protoveratrine produced bradycardia with a longer latent period. It was 
also noted that repeated injection of protoveratrine produced cardiac 
arrhythmias. 11Veriloid11 did not produce this effect. The fall in blood 
pressure produced by the first injection of 11Veri],.oid" was not different 
in the rabbit or cat, nor were the responses to the first injection 
influenced by prior vagotomy. The site of vagal section in the cat did 
not influence the fall in blood pressure since the response after bilateral 
cervical vagotomy was not different from that observed after section above 
the nodose ganglia. Combined removal of the nodose ganglia and denerva-
tion of the common carotid bifurcation did not alter the depressor response 
to 11Veriloid11 • Tachyphylaxis was demonstrated in intact and in vagotomized 
cats. "Veriloid11-induced bradycardia in the cat and rabbit was abolished 
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b.r vagotomy. For the determination of their influence on the effects of 
11Veriloid11 , five commonly used anesthetic agents were studied. The intra-
venous infusion of 11Veriloid" in animals anesthetized with pentobarbital, 
ether, alpha chloralose, Dial-urethane or morphine sulfate produced depressor 
responses of the same magnitude. Bilateral cervical vagotomy in the animals 
anesthetized with the first four of these agents did not alter the depressor 
response. In pentobarbital anesthetized dogs, the depressor response to 
"Veriloid" was not reduced by bilateral extirpation of the carotid bodies 
alone or combined with bilateral cervical vagotomy. Apparently, the vagus 
nerves are not essential for the production of the depressor response after 
administration of "Veriloid11 to rabbits, cats or dogs. The interruption 
of these nerves by either section or by cold block did not alter the 
response to 11Veriloid11 or protoveratrine. 
The role of the central nervous system in the cardiovascular effects 
of nveriloid11 , protoveratrine, veratridine or veratramine was investigated 
in a series of cross circulation experiments. The results showed that 
the substances fall into two groups. The first when administered to the 
body slowed the heart and lowered the blood pressure after atropine or 
vagotomy (veratridine or veratramine); the second group had no effect in 
the body after atropine or vagotomy (protoveratrine or 11Veriloid11). All 
the agents produced a fall in blood pressure when isolated to the head, 
but none produced slowing of the heart. Injection of solvents alone did 
not produce this effect. In the case of 11Veriloid11 or protoveratrine, 
fall of blood pressure after injection into the body was apparently 
dependent on cardiac slowing and was eliminated by atropine. Even with 
the agents capable of eliciting fall of blood pressure when administered 
to the body after vagotomy, the depressor response was associated with 
bradycardia. It seems clear that "Veriloid11 , protoveratrine, veratridine 
or veratramine act upon the central nervous system to lower blood pressure. 
The pressor action of 11Veriloid" was studied in pentobarbital anes-
thetized dogs before and after adrenergic blockade (dibenamine). In the 
intact animal an increase in blood pressure was observed. After adrenergic 
blockade, an equal dose of "Veriloid" produced a depressor effect. Toxic 
doses of 11Veriloid11 produce a pressor effect which is probably due to the 
release of endogenous epinephrine. 
The study of bradycardic activity of veratrum derivatives included: 
(a) a rapid intravenous injection of "Veriloid", acid extract of Veratrum 
viride and any one of nine pure alkaloids in anesthetized dogs, (b) 
influence of rate of administration on the cardiac effects of 11Veriloidn 
' 
(c) intravenous infusion in·to unanesthetized dogs and (d) evaluation of 
cardiac effects of repeated injections of 11 Veriloid11 or protoveratrine. 
A striking feature of these data is marked variability as a result of 
which no difference could be shown. One difference in the effect of 
these derivatives was noted, namely the incidence of arrhythmias which 
occurred after injection of veratridine, germidine, germerine or cevadine. 
A normal sinus rhythm was observed during the bradycardic response after 
germitrine, PNPlll, neogermitrine, protoveratrine, 11Veriloid11 , acid 
extract or veratramine. It was also observed that threefold increase in 
dose did not give bradycardic responses different from those observed at 
the lm·mr dose. In the anesthetized dog, 5 or 10 microgm. of 11Veriloid11 
per kgm. produced the same bradycardic response vlhether given rapidly or 
slowly; however, 20 microgm. per kgm. by infusion gave a smaller response 
than byrapid injection. Infusion of veratrum derivatives into unanes-
thetized dogs produced bradycardia which was comparable in magnitude and 
variability to that observed in anesthetized animals. Hourly injections 
of "Veriloid" or protoveratrine produced responses which were not diff erent. 
Following the second and third injection of protoveratrine, two of seven 
dogs tested exhibited cardiac arrhythmias. Veriloid produced only brady-
cardia. 
The effect of veratrosine on abnormal cardiac rates and rhythms 
produced by ten different methods was studied. It was demonstrated that 
veratrosine will protect against a variety of drug-induced supraventricular 
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tachycardias and will revert this type of abnormality to a normal sinus 
rate. It was also shown that veratrosine did not protect against ven-
tricular arrhythmias. 
I t was concluded that veratrum derivatives can produce a depressor 
response by two means: (a) by a direct action on the central nervous 
system and (b) by a reflex cardiodecelerator effect mediated by way of 
the vagus nerves. 
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